Name,Institution_Paid,Program_Name,Competition_CD,PRC_Name,Project_Title,CIHR_Contribution,CIHR_Equipment,Term_Years_Months,Primary_Institute,Research_Categories,Funding_Start,Funding_End,normalized_Project_Title
"Yokota, Toshifumi",University of Alberta,Project Grant,202203PJT,Commercialization,Commercializing a novel platform for delivery of antisense oligonucleotide-mediated therapy,"$1,009,800",$0,5 yrs 0 mth ,Genetics,Genetics-Clinical Genetics,2022-10-01,2027-09-30,commercializing a novel platform for delivery of antisense oligonucleotidemediated therapy
"Withers, Stephen G",University of British Columbia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Novel mechanism-based inhibitors of influenza neuraminidase as potential anti-viral agents,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; VIRAL; VIROLOGY; POPULATION HEALTH,2010-04-01,2011-03-31,novel mechanismbased inhibitors of influenza neuraminidase as potential antiviral agents
"Jarvi, Keith A",Sinai Health System (Toronto),Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Prediction of successful sperm retrieval in patients with non-obstructive azoospermia using TEX101 protein measured in seminal plasma by ELISA,"$160,000",$0,1 yr 0 mth ,"Human Development, Child and Youth Health","INFERTILITY MALE; PREGNANCY/BIRTH; GENOMICS, PROTEOMICS, AND BIOINFORMATICS; REPRODUCTION/PREGNANCY",2016-04-01,2017-03-31,prediction of successful sperm retrieval in patients with nonobstructive azoospermia using tex101 protein measured in seminal plasma by elisa
"Hancock, Robert Ernest W",University of British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Anti-Biofilm Therapy,"$160,000",$0,1 yr 0 mth ,Infection and Immunity,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; INFECTIOUS AND PARASITIC; BACTERIOLOGY; DRUG RESEARCH,2013-04-01,2014-03-31,antibiofilm therapy
"Ross, Ruth A",University of Toronto,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Development and Testing of Small Molecule Allosteric Modulators for the Treatment of Pain.,"$157,999",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE DISEASE RELEVANCE; ARTHRITIS/OSTEOARTHRITIS; DRUG RESEARCH; AGING,2013-04-01,2014-03-31,development and testing of small molecule allosteric modulators for the treatment of pain
"Stojdl, David F",Children's Hospital of Eastern Ontario Research Institute Inc,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Chimeric Oncolytic Virus for Brain Cancer Treatment,"$160,000",$0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; CANCER THERAPY GENERAL,2013-10-01,2014-09-30,chimeric oncolytic virus for brain cancer treatment
"Martineau, Paul A",Research Institute of the McGill University Health Centre,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,POROUS COMPRESSION SCREW for FRACTURE FIXATION,"$155,375",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"INJURY, REGENERATION; HEALTH CARE DELIVERY; HEALTH RESEARCH; MUSCLE, BONE, OR JOINT",2011-04-01,2012-03-31,porous compression screw for fracture fixation
"Hess, Robert F",McGill University,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Assessment and Treatment of Binocular Vision in Amblyopia,"$126,802",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DISEASES AFFECTING SPEECH/VISION/HEARING; VISION,2009-01-01,2009-12-31,assessment and treatment of binocular vision in amblyopia
"Weaver, Donald F",IWK Health Centre (Halifax),Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Contact Optical Microscopy,"$148,684",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE DISEASE RELEVANCE; MULTIDISCIPLINARY; IMAGING; INTERNATIONAL HEALTH,2010-04-01,2011-03-31,contact optical microscopy
"Zhang, Li",University Health Network (Toronto),Proof of Principle Program - Phase II,201502PP2,Proof of Principle,A new cellular immunotherapy to treat acute myeloid leukemia,"$183,670","$35,500",1 yr 0 mth ,Cancer Research,MULTIDISCIPLINARY; IMMUNOLOGY-TRANSPLANTATION; CANCER,2015-10-01,2016-09-30,a new cellular immunotherapy to treat acute myeloid leukemia
"Malouin, Franeois",Universite de Sherbrooke,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Riboswitch ligand inhibitors for MRSA and staphylococci / Ligands de riboregulateurs agissant comme antibiotiques contre le SARM et les staphylocoques,"$157,350",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC,2013-04-01,2014-03-31,riboswitch ligand inhibitors for mrsa and staphylococci ligands de riboregulateurs agissant comme antibiotiques contre le sarm et les staphylocoques
"Philip, Anie",Research Institute of the McGill University Health Centre,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Identification of a low molecular weight peptide of CD109 as an anti-scarring agent,"$150,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,MUSCULO SKELETAL; CANCER THERAPY GENERAL; MOLECULAR BIOLOGY; CELL BIOLOGY,2010-04-01,2011-03-31,identification of a low molecular weight peptide of cd109 as an antiscarring agent
"Ndao, Momar",Research Institute of the McGill University Health Centre,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Bridging the Gap Between Mass Spectrometric Profiling and Practical Diagnostic Tests for Commercialization: Case of Chagas Disease,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,"INFECTIOUS AND PARASITIC; PARASITIC; HEALTH RESEARCH; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",2009-01-01,2009-12-31,bridging the gap between mass spectrometric profiling and practical diagnostic tests for commercialization case of chagas disease
"Schweizer, Frank",University of Manitoba,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Optimization and preclinical studies on amphiphilic aminoglycoside antimicrobials (AAAs),"$160,000",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; HEALTH RESEARCH; DRUG RESEARCH,2012-04-01,2013-03-31,optimization and preclinical studies on amphiphilic aminoglycoside antimicrobials aaas
"Turvey, Stuart E",University of British Columbia,Proof of Principle Program Phase I - Drug Development,200904PDD,Proof of Principle,Development of a TLR5 antagonist as a novel anti-inflammatory therapy for cystic fibrosis,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,IMMUNOLOGY-TRANSPLANTATION; BIOCHEMISTRY,2009-07-01,2010-06-30,development of a tlr5 antagonist as a novel antiinflammatory therapy for cystic fibrosis
"Mishra, Ram K",McMaster University,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,A novel dopamine D2 receptor allosteric modulator: Development and commercialization of a safer more effective generation of antipsychotic drugs,"$146,850",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",SCHIZOPHRENIA; PARKINSON'S DISEASE; MENTAL HEALTH; BIOCHEMISTRY,2011-10-01,2012-09-30,a novel dopamine d2 receptor allosteric modulator development and commercialization of a safer more effective generation of antipsychotic drugs
"Withers, Stephen G",University of British Columbia,Proof of Principle Program - Phase II,201202PP2,Proof of Principle,Novel Influenza Neuraminidase Inhibitors - Development of Orally Bioavailable Agents,"$297,000",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; VIROLOGY; POPULATION HEALTH,2012-10-01,2013-09-30,novel influenza neuraminidase inhibitors development of orally bioavailable agents
"Sheardown, Heather D",McMaster University,Project Grant,202109PJT,Commercialization,A novel eye drop platform to improve ocular therapies,"$531,674",$0,3 yrs 0 mth ,Aging,"Commercialization-Technology Transfer; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",2022-04-01,2025-03-31,a novel eye drop platform to improve ocular therapies
"Wasan, Kishor M",University of British Columbia,Proof of Principle Program - Phase II,200810PP2,Proof of Principle,Development of a Novel Oral Amphotericin B Formulation for the Treatment of Systemic Fungal Infections,"$200,000",$0,1 yr 0 mth ,Infection and Immunity,,2009-01-01,2009-12-31,development of a novel oral amphotericin b formulation for the treatment of systemic fungal infections
"Li, Shyh-Dar","Ontario Institute for Cancer Research (Toronto, Ontario)",Proof of Principle Program - Phase I,201202PPP,Proof of Principle,"Benchmark Cellax, a proprietary nanoparticle formulation for docetaxel, against Taxotere to treat metastatic castration resistant prostate cancer","$160,000",$0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; DRUG RESEARCH; CANCER,2012-10-01,2013-09-30,benchmark cellax a proprietary nanoparticle formulation for docetaxel against taxotere to treat metastatic castration resistant prostate cancer
"Jarvi, Keith A",Sinai Health System (Toronto),Proof of Principle Program - Phase I,201009PPP,Proof of Principle,"Novel semen biomarkers to identify sperm production in men with infertility: A non-invasive method to characterize men with azoospermia or no sperm in the semen, into those with and without testicular sperm production","$152,499",$0,1 yr 0 mth ,"Human Development, Child and Youth Health",INFERTILITY MALE; GENITO/URINARY SYSTEM; ENDOCRINOLOGY; REPRODUCTION/PREGNANCY,2011-04-01,2012-03-31,novel semen biomarkers to identify sperm production in men with infertility a noninvasive method to characterize men with azoospermia or no sperm in the semen into those with and without testicular sperm production
"Kelley, Shana O",University of Toronto,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,The xViva CTC capture chip: a device for tumor cell sorting and classification,"$160,000",$0,1 yr 0 mth ,Genetics,PROSTATE AND BLADDER CANCER; CANCER THERAPY GENERAL; GENETICS; CANCER,2014-10-01,2015-09-30,the xviva ctc capture chip a device for tumor cell sorting and classification
"Braverman, Nancy E",Research Institute of the McGill University Health Centre,Project Grant,202209PJT,Commercialization,Enabling commercialization of retinal gene therapy for Zellweger Spectrum Disorder,"$1,503,225",$0,5 yrs 0 mth ,Genetics,"Commercialization-Technology Transfer; Neurosciences-Sensory Systems (including visual, auditory and pain); Genetic disease",2023-04-01,2028-03-31,enabling commercialization of retinal gene therapy for zellweger spectrum disorder
"Yudin, Andrei",University of Toronto,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Arrays of constrained histone tail mimetics for the development of epigenetic anticancer drugs,"$85,712","$74,288",1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER THERAPY GENERAL; DRUG RESEARCH; CANCER,2011-10-01,2012-09-30,arrays of constrained histone tail mimetics for the development of epigenetic anticancer drugs
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Cancer vaccines targeting the ganglioside tumor-marker GD2,"$157,600",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER; IMMUNOLOGY-TRANSPLANTATION,2012-10-01,2013-09-30,cancer vaccines targeting the ganglioside tumormarker gd2
"Gong, Siew-Ging",University of Toronto,Project Grant,202203PJT,Commercialization,Streptococcus salivarius Probiotics Against Dental Caries Pathogens,"$535,501",$0,4 yrs 0 mth ,Musculoskeletal Health and Arthritis,"Commercialization-Intellectual Property; Health Determinants-Etiology of Disease and Conditions; Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",2022-10-01,2026-09-30,streptococcus salivarius probiotics against dental caries pathogens
"Kumar, Rakesh",University of Alberta,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Development of new class of antiviral drugs for influenza A virus infections,"$156,590",$0,1 yr 0 mth ,Infection and Immunity,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; INFECTIOUS AND PARASITIC; HEALTH RESEARCH; DRUG RESEARCH,2013-04-01,2014-03-31,development of new class of antiviral drugs for influenza a virus infections
"Conway, Edward M",University of British Columbia,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Novel therapeutic approach for 'wet' and 'dry' age-related macular degeneration,"$160,000",$0,1 yr 0 mth ,Aging,DISEASES AFFECTING SPEECH/VISION/HEARING; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; AGING,2014-10-01,2015-09-30,novel therapeutic approach for wet and dry agerelated macular degeneration
"Coles, John G",Hospital for Sick Children (Toronto),Project Grant,201709PJT,Commercialization,Integrin Linked Kinase as a Novel Therapeutic Target for Heart Failure,"$512,550",$0,3 yrs 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Cardiovascular and Circulatory Sciences",2018-04-01,2021-03-31,integrin linked kinase as a novel therapeutic target for heart failure
"Dmitrienko, Gary I",University of Waterloo (Ontario),Proof of Principle Program Phase I - Drug Development,200904PDD,Proof of Principle,Novel beta lactamase inhibitors to combat antibiotic resistance,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; DRUG RESEARCH; BACTERIOLOGY,2009-07-01,2010-06-30,novel beta lactamase inhibitors to combat antibiotic resistance
"Ma, Hongshen",University of British Columbia,Project Grant,201909PJT,Commercialization,Non-contact screening technology to expedite cell line development for antibody production,"$524,026",$0,3 yrs 0 mth ,Cancer Research,"Commercialization-Intellectual Property; Commercialization-Technology Transfer; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",2020-04-01,2023-03-31,noncontact screening technology to expedite cell line development for antibody production
"Alfieri, Carolina","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Development of a peptide mimetic vaccine for prevention of Epstein-Barr virus infectious mononucleosis and related cancers.,"$159,612",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; INFECTIOUS AND PARASITIC; VIROLOGY; IMMUNOLOGY-TRANSPLANTATION,2014-10-01,2015-09-30,development of a peptide mimetic vaccine for prevention of epsteinbarr virus infectious mononucleosis and related cancers
"Rogers, Ian M",Sinai Health System (Toronto),Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Cell therapy for the treatment of type 1 Diabetes,"$150,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; METABOLISM/DIABETES,2010-04-01,2011-03-31,cell therapy for the treatment of type 1 diabetes
"Whyne, Cari M","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Proof of Principle Program - Phase I,201509PPP,Proof of Principle,"""Bone Tape"": Optimization of a novel method for reconstructing the craniomaxillofacial skeleton","$160,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT",2016-04-01,2017-03-31,bone tape optimization of a novel method for reconstructing the craniomaxillofacial skeleton
"Gobbi, Gabriella",McGill University,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Novel first-in-class MT2 melatonin receptor partial agonists for neuropathic pain,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; MENTAL AND BEHAVIOURAL DISEASES; DRUG RESEARCH; NERVOUS SYSTEM,2016-04-01,2017-03-31,novel firstinclass mt2 melatonin receptor partial agonists for neuropathic pain
"Moreau, Alain","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Proof of Principle Program - Phase II,200904PP2,Proof of Principle,Methods of Diagnosing Idiopathic Scoliosis and related Spinal Disorders,"$250,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; MOLECULAR BIOLOGY",2009-07-01,2010-06-30,methods of diagnosing idiopathic scoliosis and related spinal disorders
"Li, Shyh-Dar",University of British Columbia,Project Grant,201909PJT,Commercialization,Validation and commercialization of an innovative analgesic for chronic pain,"$524,026",$0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",2020-04-01,2023-03-31,validation and commercialization of an innovative analgesic for chronic pain
"Sherar, Michael D",University Health Network (Toronto),Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Treatment Planning and Guidance Software Platform for Minimally Invasive Ablation Therapies,"$145,925","$10,000",1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; BIOPHYSICS; CANCER,2013-04-01,2014-03-31,treatment planning and guidance software platform for minimally invasive ablation therapies
"Tamimi, Faleh",McGill University,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Biocompatible inorganic nanogel system for medical applications,"$150,160",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; INJURY, REGENERATION; DENTAL SCIENCE - Oral Biology; DRUG RESEARCH",2013-04-01,2014-03-31,biocompatible inorganic nanogel system for medical applications
"Daugaard, Mads",University of British Columbia,Project Grant,202403PJT,Commercialization,An integrated AI-powered platform for cell analytics,"$730,576",$0,4 yrs 0 mth ,Cancer Research,Commercialization-Technology Transfer; Artificial Intelligence-Machine Learning; Methods Development and Modelling-Qualitative Methods Development for Health Research,2024-10-01,2028-09-30,an integrated aipowered platform for cell analytics
"Zeng, Haishan",University of British Columbia,Project Grant,201709PJT,Commercialization,Real-time Endoscopic Raman Spectroscopy for Improving Dysplasia/Colorectal Cancer Detection in Patients with Inflammatory Bowel Diseases,"$508,724",$0,4 yrs 0 mth ,Cancer Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Cancer-Clinical Oncology; Digestive, Endocrine and Excretory Systems-Gastroenterology and Hepatology",2018-04-01,2022-03-31,realtime endoscopic raman spectroscopy for improving dysplasiacolorectal cancer detection in patients with inflammatory bowel diseases
"Glogauer, Michael",University of Toronto,Proof of Principle Program - Phase II,200904PP2,Proof of Principle,Clinical Evaluation of a Chair-side In Vitro Rinse Test for Predicting Onset and Recurrent Adult Periodontitis,"$88,399",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,DENTAL DISEASE (INCL. ORAL BIOLOGY); DENTAL SCIENCE - Oral Biology; IMMUNOLOGY-TRANSPLANTATION,2009-07-01,2010-06-30,clinical evaluation of a chairside in vitro rinse test for predicting onset and recurrent adult periodontitis
"Webb, John R",University of Victoria (British Columbia),Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Pre-clinical development of Pentarix: a therapeutic vaccine for HPV-associated cancers,"$160,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; VIRAL; CANCER; IMMUNOLOGY-TRANSPLANTATION,2010-10-01,2011-09-30,preclinical development of pentarix a therapeutic vaccine for hpvassociated cancers
"Schrader, John W",University of British Columbia,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Preclinical evaluation of a truly human monoclonal antibody for the therapy of infections with a broad spectrum of influenza viruses,"$160,000",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; IMMUNOLOGY-TRANSPLANTATION; DRUG RESEARCH,2011-04-01,2012-03-31,preclinical evaluation of a truly human monoclonal antibody for the therapy of infections with a broad spectrum of influenza viruses
"Yang, Victor X",Toronto Metropolitan University,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Doppler Optical Coherence Tomography for Intraoperative Imaging During Skull Base Neurosurgical Procedures,"$149,984",$0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; IMAGING; BIOPHYSICS,2010-04-01,2011-03-31,doppler optical coherence tomography for intraoperative imaging during skull base neurosurgical procedures
"Roberge, Michel",University of British Columbia,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Preclinical Development of a novel M2 Channel Inhibitor for the Treatment and Prevention of Influenza,"$160,000",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; VIROLOGY,2014-04-01,2015-03-31,preclinical development of a novel m2 channel inhibitor for the treatment and prevention of influenza
"Olson, David M",University of Alberta,Project Grant,202003PJT,Commercialization,Integrated discovery studies and commercialization for a preterm birth diagnostic and a therapeutic,"$558,450",$0,3 yrs 0 mth ,"Human Development, Child and Youth Health",Commercialization-Industry Research & Development; Reproduction and Development-Fertility and Maternal Health,2020-10-01,2023-09-30,integrated discovery studies and commercialization for a preterm birth diagnostic and a therapeutic
"Zhang, Li",University Health Network (Toronto),Project Grant,201903PJT,Commercialization,"Developing a platform for ""off-the-shelf"" CAR-T cell therapies for cancer using double negative T cells","$703,800",$0,4 yrs 0 mth ,Cancer Research,Commercialization-Technology Transfer; Cancer-Cancer Drug Development and Therapeutics,2019-10-01,2023-09-30,developing a platform for offtheshelf cart cell therapies for cancer using double negative t cells
"Haddad, Elie","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Project Grant - PA: Breast Cancer Research,202109PLL,Commercialization,Platform of synthetic specific promoters for immunotherapies and regenerative medicine,"$100,000",$0,1 yr 0 mth ,Cancer Research,Commercialization-Intellectual Property; Commercialization-Technology Transfer; Cancer-Cancer Drug Development and Therapeutics,2022-03-01,2023-03-31,platform of synthetic specific promoters for immunotherapies and regenerative medicine
"Adeli, Khosrow",Hospital for Sick Children (Toronto),Operating Grant: Industry-partnered Collaborative Research - Rx&D partner,201103IRO,Industry Partnered Collaborative Research,CALIPER: A Canadian Initiative to Close the Critical Gaps in Pediatric Reference Intervals,"$66,667",$0,1 yr 0 mth,"Human Development, Child and Youth Health",HEALTH CARE DELIVERY; HEALTH SERVICES RESEARCH; HEALTH RESEARCH; POPULATION HEALTH,2011-10-01,2012-09-30,caliper a canadian initiative to close the critical gaps in pediatric reference intervals
"Ghahary, Aziz",University of British Columbia,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Re -constitutable skin substitute powder kit,"$147,089",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; INJURY, REGENERATION",2014-04-01,2015-03-31,re constitutable skin substitute powder kit
"Andersen, Raymond J",University of British Columbia,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,"Latonduine A, A Potent delF508-CFTR Trafficking Defect Corrector With Potential for Treating Cystic Fibrosis","$159,750",$0,1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; INFECTIOUS AND PARASITIC; DRUG RESEARCH,2010-10-01,2011-09-30,latonduine a a potent delf508cftr trafficking defect corrector with potential for treating cystic fibrosis
"Wu, Xiao Yu S",University of Toronto,Project Grant,201809PJT,Commercialization,Development of a Smart Tumor-Activated Nanodiagnostic System for Sensitive Detection of Solid Tumors and Metastases,"$470,475",$0,3 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property; Biomedical Engineering-Biomedical Imaging,2019-04-01,2022-03-31,development of a smart tumoractivated nanodiagnostic system for sensitive detection of solid tumors and metastases
"Legault, Pascale",Universite de Montreal,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,The ARiBo technology for isolation of ribonucleoprotein complexes,"$145,412","$13,349",1 yr 0 mth ,Genetics,"CANCER THERAPY GENERAL; MULTIPLE DISEASE RELEVANCE; BIOCHEMISTRY; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",2012-10-01,2013-09-30,the aribo technology for isolation of ribonucleoprotein complexes
"Leavitt, Blair R",University of British Columbia,Operating Grant - PA: Genetics (Bridge Funding: Research Priorities) + Project Grant,"202109OGB, 202203PJT",Commercialization,Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.,"$861,176",$0,6 yr 0 mth ,Genetics,"Commercialization-Industry Research & Development; Neurosciences-Neurological disorders; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",2022-03-01,2023-02-28,lipid nanoparticlemediated delivery of crisprcas9 gene editing for neurological disorders
"Dmitrienko, Gary I",University of Waterloo (Ontario),Proof of Principle Program - Phase II,201009PP2,Proof of Principle,New drugs for antibiotic resistant bacterial infections,"$133,277",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; DRUG RESEARCH; BIOCHEMISTRY,2011-04-01,2012-03-31,new drugs for antibiotic resistant bacterial infections
"Sanche, Leon",Universite de Sherbrooke,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Developpement de composes antineoplasiques radiosensibilisants achemines par nano transporteur liposomal.,"$159,149",$0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; BRAIN TUMORS THERAPY; CANCER; DRUG RESEARCH,2012-10-01,2013-09-30,developpement de composes antineoplasiques radiosensibilisants achemines par nano transporteur liposomal
"Paganelli, Massimiliano","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Project Grant,201809PJT,Commercialization,Stem cell-derived Encapsulated Liver Tissue to treat liver failure without immunosuppression: technology maturation towards clinical translation,"$497,249",$0,3 yrs 0 mth ,"Nutrition, Metabolism and Diabetes","Biomedical Engineering-Regenerative Medicine and Tissue Engineering; Digestive, Endocrine and Excretory Systems-Gastroenterology and Hepatology; Commercialization-Technology Transfer",2019-04-01,2022-03-31,stem cellderived encapsulated liver tissue to treat liver failure without immunosuppression technology maturation towards clinical translation
"Alaoui-Jamali, Moulay A",McGill University,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Triple Targeted Kinase Inhibitors Capable of Inhibiting Breast Cancer Metastases,"$160,000",$0,1 yr 0 mth ,Cancer Research,BREAST CANCER THERAPY; BREAST CANCER; CANCER; DRUG RESEARCH,2011-10-01,2012-09-30,triple targeted kinase inhibitors capable of inhibiting breast cancer metastases
"Salcudean, Septimiu E",University of British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Real-time Ultrasound Quantitative Elastography of the Prostate,"$143,074","$10,850",1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; IMAGING; CANCER,2013-04-01,2014-03-31,realtime ultrasound quantitative elastography of the prostate
"Husain, Mansoor",University Health Network (Toronto),Proof of Principle Program - Phase II,201202PP2,Proof of Principle,Development of an anti-proliferative therapeutic that disrupts CaM-cyclin E interactions in vivo.,"$184,100","$10,600",1 yr 0 mth ,Circulatory and Respiratory Health,ATHEROSCLEROSIS; CANCER THERAPY GENERAL; CARDIOVASCULAR; CELL BIOLOGY,2012-10-01,2013-09-30,development of an antiproliferative therapeutic that disrupts camcyclin e interactions in vivo
"Lubell, William D",Universite de Montreal,Project Grant,202303PJT,Commercialization,Interleukin-1 Receptor Modulating Therapy for Treating Macular Degeneration,"$516,376",$0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Commercialization-Industry Research & Development; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery; Aging-Geriatric Medicine and Health Sciences",2023-10-01,2026-09-30,interleukin1 receptor modulating therapy for treating macular degeneration
"St-Pierre, Yves","INRS - (Quebec, QC)",Project Grant,201809PJT,Commercialization,GAL-7-specific nanobodies for treatment of triple-negative breast cancer,"$371,024",$0,3 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property,2019-04-01,2022-03-31,gal7specific nanobodies for treatment of triplenegative breast cancer
"Huntsman, David G",University of British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,PrOTYPE: An Enabling Technology to Improve Ovarian Cancer Care,"$154,829",$0,1 yr 0 mth ,Cancer Research,"NEOPLASMS; NONE OF THE ABOVE; CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",2013-04-01,2014-03-31,protype an enabling technology to improve ovarian cancer care
"Mossman, Karen L",McMaster University,Project Grant,202104PJT,Commercialization,Clinical development of oncolytic BHV-1 for cancer therapy,"$504,900",$0,3 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property; Commercialization-Industry Research & Development; Cancer-Cancer Drug Development and Therapeutics,2021-10-01,2024-09-30,clinical development of oncolytic bhv1 for cancer therapy
"Walti, Herve",Universite de Sherbrooke,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Total liquid ventilation improves respiratory and neurological outcomes in newborn lambs with severe respiratory failure,"$159,252",$0,1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; PERINATAL; NOT CLASSIFIED,2012-10-01,2013-09-30,total liquid ventilation improves respiratory and neurological outcomes in newborn lambs with severe respiratory failure
"Kouassi, Edouard",CIUSSS Est-de-l'Ile-de- Montreal-Maisonneuve Rosemont,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Novel methods and compounds for increasing red blood cell survival,"$160,000",$0,1 yr 0 mth ,Circulatory and Respiratory Health,BLOOD; ANAEMIAS; DRUG RESEARCH,2010-10-01,2011-09-30,novel methods and compounds for increasing red blood cell survival
"Cashman, Neil R",University of British Columbia,Proof of Principle Program - Phase II,201209PP2,Proof of Principle,A defined cyclic peptide epitope specific to Abeta oligomers:   Active and passive vaccination in mouse models of Alzheimer's disease,"$300,000",$0,1 yr 0 mth ,Aging,ALZHEIMER'S DISEASE; AGING; NERVOUS SYSTEM,2013-04-01,2014-03-31,a defined cyclic peptide epitope specific to abeta oligomers active and passive vaccination in mouse models of alzheimers disease
"Garnis, Cathie",University of British Columbia,Project Grant,201809PJT,Commercialization,Blood based biomarker for the early detection of recurrent head and neck cancer,"$539,324",$0,4 yrs 0 mth ,Cancer Research,Cancer-Clinical Oncology,2019-04-01,2023-03-31,blood based biomarker for the early detection of recurrent head and neck cancer
"Mahony, James B",McMaster University,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Evaluation of a Novel Chlamydia Vaccine Based on Type III Secretion Proteins,"$159,000",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; INFERTILITY FEMALE; HEALTH RESEARCH; BACTERIOLOGY,2014-10-01,2015-09-30,evaluation of a novel chlamydia vaccine based on type iii secretion proteins
"Alman, Benjamin A",Hospital for Sick Children (Toronto),Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Nefopam as an agent to prevent and treat hyperplastic scars,"$159,975",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; DRUG RESEARCH",2010-10-01,2011-09-30,nefopam as an agent to prevent and treat hyperplastic scars
"Waldman, Stephen D","Queen's University (Kingston, Ontario)",Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Tissue engineered cartilage suitable for the repair of clinically-relevant sized defects,"$148,139",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"INJURY, REGENERATION; ARTHRITIS/OSTEOARTHRITIS; MUSCLE, BONE, OR JOINT; BIOPHYSICS",2010-04-01,2011-03-31,tissue engineered cartilage suitable for the repair of clinicallyrelevant sized defects
"Willerth, Stephanie M",University of Victoria (British Columbia),Project Grant,202104PJT,Commercialization,3D bioprinting next generation brain organoids for identifying drug targets for Alzheimer's disease,"$489,600",$0,4 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Biomedical Engineering-Regenerative Medicine and Tissue Engineering; Molecular, Cellular and Systems Biology-Cell Differentiation",2021-10-01,2025-09-30,3d bioprinting next generation brain organoids for identifying drug targets for alzheimers disease
"Zeng, Haishan",University of British Columbia,Proof of Principle Program - Phase II,201009PP2,Proof of Principle,Development of a laser Raman spectroscopy system for melanoma detection,"$244,071","$48,211",1 yr 0 mth ,Cancer Research,MULTIDISCIPLINARY; SKIN AND SUBCUTANEOUS TISSUS; CANCER; IMAGING,2011-04-01,2012-03-31,development of a laser raman spectroscopy system for melanoma detection
"Kubow, Stanley",McGill University,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Protective Effects of Potato Polyphenol-Rich Extracts Against Lung Damage Caused by Air Pollutants,"$150,525",$0,1 yr 0 mth ,Circulatory and Respiratory Health,ENVIRONMENTAL INFLUENCES ON HEALTH; RESPIRATION; NUTRITION,2012-04-01,2013-03-31,protective effects of potato polyphenolrich extracts against lung damage caused by air pollutants
"Underhill, Michael",University of British Columbia,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Novel Applications of Potassium Channel Blockers in Arthritis,"$146,400",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"ARTHRITIS/OSTEOARTHRITIS; MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; AGING",2011-04-01,2012-03-31,novel applications of potassium channel blockers in arthritis
"Petrecca, Kevin",McGill University,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Identification of Novel Compounds Inhibiting Brain Cancer Invasion,"$120,775",$0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; NEOPLASMS; CANCER; DRUG RESEARCH,2011-04-01,2012-03-31,identification of novel compounds inhibiting brain cancer invasion
"Crystal, Eugene","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Three-dimensional Catheter Tracking using a Single Two-dimensional Image,"$130,077","$12,873",1 yr 0 mth ,Circulatory and Respiratory Health,CARDIOLOGY; ARRHYTHMIAS; IMAGING; CARDIOVASCULAR,2010-04-01,2011-03-31,threedimensional catheter tracking using a single twodimensional image
"Granville, David J",University of British Columbia,Proof of Principle Program - Phase II,200910PP2,Proof of Principle,Therapeutic antibody development towards granzyme B,"$101,240",$0,1 yr 0 mth ,Circulatory and Respiratory Health,NONE OF THE ABOVE; AGING; CARDIOVASCULAR,2010-04-01,2011-03-31,therapeutic antibody development towards granzyme b
"Brouillette, Martin",Universite de Sherbrooke,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Device for recanalization of peripheral and coronary arteries,"$155,180",$0,1 yr 0 mth ,Circulatory and Respiratory Health,CORONARY CIRCULATION (INCL. INSUFFICIENCY); CARDIOLOGY; CARDIOVASCULAR,2013-10-01,2014-09-30,device for recanalization of peripheral and coronary arteries
"Tessier, Philippe A",Universite Laval,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Development of anti-S100 proteins for the treatment of arthritis,"$142,600",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"ARTHRITIS/OSTEOARTHRITIS; CHRONIC INFLAMMATORY BOWEL DISEASE; IMMUNOLOGY-TRANSPLANTATION; MUSCLE, BONE, OR JOINT",2009-07-01,2010-06-30,development of antis100 proteins for the treatment of arthritis
"Ostrowski, Mario A",University of Toronto,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Bioreactor-based large scale production of a Tim-3 pathway inhibitor as a novel immunotherapy against HIV-1 and other chronic viral infections,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,AIDS; INFECTIOUS AND PARASITIC; IMMUNOLOGY-TRANSPLANTATION; VIROLOGY,2009-01-01,2009-12-31,bioreactorbased large scale production of a tim3 pathway inhibitor as a novel immunotherapy against hiv1 and other chronic viral infections
"Rak, Janusz",Research Institute of the McGill University Health Centre,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Monitoring progression of malignant tumors by detection of blood-borne oncogenic epidermal growth factor receptor circulating as cargo of tumor-derived microvesicles,"$150,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; BRAIN TUMORS THERAPY; CANCER; CELL BIOLOGY,2009-01-01,2009-12-31,monitoring progression of malignant tumors by detection of bloodborne oncogenic epidermal growth factor receptor circulating as cargo of tumorderived microvesicles
"Gross, Peter L",McMaster University,Project Grant,202203PJT,Commercialization,Benchmarking a point-of-care test kit for detection of direct-oral anticoagulants,"$279,225",$0,2 yrs 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Vascular and Endothelial Biology; Commercialization-Intellectual Property; Cardiovascular, Respiratory and Circulatory Systems-Hematology",2022-10-01,2024-09-30,benchmarking a pointofcare test kit for detection of directoral anticoagulants
"Liu, Fei-Fei",University Health Network (Toronto),Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Targeting UROD As A Novel Anti-Cancer Therapeutic Strategy,"$150,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,2010-04-01,2011-03-31,targeting urod as a novel anticancer therapeutic strategy
"Walker, Gilbert C",University of Toronto,Project Grant,202403PJT,Commercialization,Development of preclinical data for a phase one clinical trial of a micro-RNA-based formulation to treat early sepsis,"$508,725",$0,2 yrs 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Respiratory System Pathologies and Clinical Interventions; Commercialization-Technology Transfer; Cardiovascular, Respiratory and Circulatory Systems-Clinical and Translational Cardiovascular Sciences",2024-10-01,2026-09-30,development of preclinical data for a phase one clinical trial of a micrornabased formulation to treat early sepsis
"Lin, Sheng-Xiang",Universite Laval,Project Grant - PA: Breast Cancer Research,202309PLL,Commercialization,Pre-clinical pharmacokinetic and efficacy assays with an efficient 17beta-hydroxysteroid dehydrogenase type 7 inhibitor for breast cancer therapy,"$100,000",$0,1 yr 0 mth ,Cancer Research,"Cancer-Cancer Drug Development and Therapeutics; Digestive, Endocrine and Excretory Systems-Endocrinology",2024-03-01,2025-02-28,preclinical pharmacokinetic and efficacy assays with an efficient 17betahydroxysteroid dehydrogenase type 7 inhibitor for breast cancer therapy
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Proof of Principle Program - Phase II,201509PP2,Proof of Principle,Therapy for motor neuron degeneration diseases targeting the opposing ligand-dependent signals of two TrkC receptor isoforms,"$300,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",AMYOTROPHIC LATERAL SCLEROSIS (ALS); DISEASES AFFECTING SPEECH/VISION/HEARING; NERVOUS SYSTEM; DRUG RESEARCH,2016-04-01,2017-03-31,therapy for motor neuron degeneration diseases targeting the opposing liganddependent signals of two trkc receptor isoforms
"C.-Gaudreault, Rene",Universite Laval,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Optimization and Validation of Highly Cytocidal Substituted Phenyl Imidazolidin-2-one as Antimicrotubule Agents for Cancer Chemotherapy,"$160,000",$0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER THERAPY GENERAL; DRUG RESEARCH; CANCER,2011-10-01,2012-09-30,optimization and validation of highly cytocidal substituted phenyl imidazolidin2one as antimicrotubule agents for cancer chemotherapy
"DeWitte-Orr, Stephanie","Wilfrid Laurier University (Waterloo, Ontario)",Project Grant - PA: Pandemic Preparedness and Health Emergencies Research,202209PPE,Commercialization,Developing intranasal dsRNA molecules as broadly effective therapeutics against highly pathogenic coronaviruses,"$100,000",$0,1 yr 0 mth ,Infection and Immunity,"Immunology and Infection-Virology; Commercialization-Intellectual Property; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",2023-03-01,2024-02-29,developing intranasal dsrna molecules as broadly effective therapeutics against highly pathogenic coronaviruses
"Rogers, Ian M",Sinai Health System (Toronto),Proof of Principle Program - Phase I,201009PPP,Proof of Principle,The Use of Multipotential Stem Cells for the Treatment of Peripheral Vascular Disease,"$160,000",$0,1 yr 0 mth ,Circulatory and Respiratory Health,NONE OF THE ABOVE; CORONARY CIRCULATION (INCL. INSUFFICIENCY); NOT CLASSIFIED; CARDIOVASCULAR,2011-04-01,2012-03-31,the use of multipotential stem cells for the treatment of peripheral vascular disease
"Sipione, Simonetta",University of Alberta,Proof of Principle Program Phase I - Drug Development,201102PDD,Proof of Principle,Development of ganglioside-based therapies for Huntington's disease,"$159,196",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",HUNTINGTON'S DISEASE; MULTIPLE DISEASE RELEVANCE; NERVOUS SYSTEM; CELL BIOLOGY,2011-10-01,2012-09-30,development of gangliosidebased therapies for huntingtons disease
"Burt, Helen M",University of British Columbia,Proof of Principle Program - Phase II,201302PP2,Proof of Principle,Intravesical Docetaxel Formulation for the Treatment of Ta/T1 Stage Bladder Cancer,"$294,600",$0,1 yr 0 mth ,Cancer Research,"PROSTATE AND BLADDER CANCER THERAPY; CANCER; RENAL FUNCTION, NEPHROLOGY, UROLOGY",2013-10-01,2014-09-30,intravesical docetaxel formulation for the treatment of tat1 stage bladder cancer
"Arthur, Gilbert",University of Manitoba,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Preclinical development of glycerophosphocarbamates as prostate-selective anticancer drugs,"$137,617",$0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; CANCER THERAPY GENERAL; CANCER; DRUG RESEARCH,2009-07-01,2010-06-30,preclinical development of glycerophosphocarbamates as prostateselective anticancer drugs
"Liu, Fang",Centre for Addiction and Mental Health (Toronto),Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Development of peptide therapeutics via nasal delivery for major depression disorder,"$150,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DEPRESSION; MENTAL AND BEHAVIOURAL DISEASES; MENTAL HEALTH; DRUG RESEARCH,2012-04-01,2013-03-31,development of peptide therapeutics via nasal delivery for major depression disorder
"Gratzer, Paul F",Dalhousie University (Nova Scotia),Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Decellularization of Human Skin,"$149,034","$10,900",1 yr 0 mth ,Musculoskeletal Health and Arthritis,SKIN AND SUBCUTANEOUS TISSUS; IMMUNOLOGY-TRANSPLANTATION; NOT CLASSIFIED,2011-04-01,2012-03-31,decellularization of human skin
"Cherkasov, Artem",University of British Columbia,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,First-in-Class Small-molecule Inhibitors Selectively Targeting the DNA-binding Domain of Human Androgen Receptor and Its Splice Variants for the Treatment of Resistant Prostate Cancer,"$150,030",$0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; CANCER THERAPY GENERAL; CANCER; DRUG RESEARCH,2014-10-01,2015-09-30,firstinclass smallmolecule inhibitors selectively targeting the dnabinding domain of human androgen receptor and its splice variants for the treatment of resistant prostate cancer
"Zeng, Haishan",University of British Columbia,Project Grant,202104PJT,Commercialization,Autofluorescence Imaging Guided Laser Raman Spectroscopy for Non-invasive Oral Cancer Detection,"$742,051",$0,4 yrs 0 mth ,Cancer Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Cancer-Clinical Oncology; Musculoskeletal Health-Oral Health",2021-10-01,2025-09-30,autofluorescence imaging guided laser raman spectroscopy for noninvasive oral cancer detection
"Diamandis, Eleftherios P",Sinai Health System (Toronto),Project Grant,202203PJT,Commercialization,"KaliDerm Therapeutics: A research/commercialization plan to validate, better define and add value to our proprietary dual KLK5/7 inhibitor as a novel topical therapeutic for Netherton Syndrome.","$336,600",$0,2 yrs 0 mth ,Infection and Immunity,"Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",2022-10-01,2024-09-30,kaliderm therapeutics a researchcommercialization plan to validate better define and add value to our proprietary dual klk57 inhibitor as a novel topical therapeutic for netherton syndrome
"Powell, William S",McGill University,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Development of novel OXE receptor antagonists for asthma,"$146,000",$0,1 yr 0 mth ,Circulatory and Respiratory Health,ASTHMA; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; RESPIRATION,2009-07-01,2010-06-30,development of novel oxe receptor antagonists for asthma
"Powell, William S",McGill University,Proof of Principle Program - Phase II,201309PP2,Proof of Principle,Development of novel OXE receptor antagonists for asthma,"$293,133",$0,1 yr 0 mth ,Circulatory and Respiratory Health,ASTHMA; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; RESPIRATION,2009-07-01,2010-06-30,development of novel oxe receptor antagonists for asthma
"Gobeil, Fernand J",Universite de Sherbrooke,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Agonistes synthetiques de kinines : Optimiser la livraison et l'efficacite des chimiotherapies des tumeurs cerebrales,"$149,418",$0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; BRAIN TUMORS (INCL. RETINAL TUMORS); CANCER; HEALTH RESEARCH,2012-04-01,2013-03-31,agonistes synthetiques de kinines optimiser la livraison et lefficacite des chimiotherapies des tumeurs cerebrales
"Macaulay, Calum E",University of British Columbia,"Proof of Principle - PA: Cancer Early Detection, Imaging/Trans Therapeutics",200904PCA,Proof of Principle,A platform enabling personalized medicine through the detection of cells with specific genetic characterization,"$149,825",$0,1 yr 0 mth ,Cancer Research,"CANCER THERAPY GENERAL; MULTIDISCIPLINARY; CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",2009-07-01,2010-06-30,a platform enabling personalized medicine through the detection of cells with specific genetic characterization
"McNagny, Kelly M",University of British Columbia,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,CD34 as a therapeutic target for allergic asthma,"$160,000",$0,1 yr 0 mth ,Infection and Immunity,ASTHMA; RESPIRATION; IMMUNOLOGY-TRANSPLANTATION,2010-10-01,2011-09-30,cd34 as a therapeutic target for allergic asthma
"Guertin, Pierre",Universite Laval,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,First-in-class Therapeutic Against Urinary Retention (Continence) in Patients with Chronic Spinal Cord Injury and Related Disorders,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction","SPINAL CORD DISEASE; GENITO/URINARY SYSTEM; NERVOUS SYSTEM; RENAL FUNCTION, NEPHROLOGY, UROLOGY",2012-04-01,2013-03-31,firstinclass therapeutic against urinary retention continence in patients with chronic spinal cord injury and related disorders
"Juncker, David",McGill University,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Clinical validation of an innovative multiplex antibody microarray platform,"$150,000",$0,1 yr 0 mth ,Cancer Research,"MULTIDISCIPLINARY; BREAST CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS; CANCER",2010-04-01,2011-03-31,clinical validation of an innovative multiplex antibody microarray platform
"Seidah, Nabil G",Institut de recherches cliniques de Montreal,Proof of Principle Program - Phase II,201209PP2,Proof of Principle,Validation of PCSK9 single domain antibodies in cholesterol regulation in humanized mice,"$186,128",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; METABOLISM AND NUTRITION; CARDIOVASCULAR; METABOLISM/DIABETES,2013-04-01,2014-03-31,validation of pcsk9 single domain antibodies in cholesterol regulation in humanized mice
"Bear, Christine E",Hospital for Sick Children (Toronto),Project Grant,202403PJT,Commercialization,Preclinical studies of a novel CFTR potentiator for commercialization as a therapy for chronic obstructive pulmonary disease.,"$325,125",$0,2 yrs 0 mth ,Circulatory and Respiratory Health,Commercialization-Technology Transfer,2024-10-01,2026-09-30,preclinical studies of a novel cftr potentiator for commercialization as a therapy for chronic obstructive pulmonary disease
"Towler, Mark R",Toronto Metropolitan University,Project Grant,201803PJT,Commercialization,"Development of a Proprietary, Glass-Based Adhesive for Sternal Fixation and Stabilisation.","$602,438",$0,3 yrs 0 mth ,Musculoskeletal Health and Arthritis,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Musculoskeletal Health-Bone, Skin and Cartilage Sciences",2018-10-01,2021-09-30,development of a proprietary glassbased adhesive for sternal fixation and stabilisation
"Finlay, Barton B",University of British Columbia,Proof of Principle Program - Phase II,201009PP2,Proof of Principle,A sub-unit based vaccine for Salmonella,"$149,685",$0,1 yr 0 mth ,Infection and Immunity,GASTRO-INTESTINAL DISEASE; INFECTIOUS AND PARASITIC; BACTERIOLOGY; GASTROINTESTINAL (LIVER),2011-04-01,2012-03-31,a subunit based vaccine for salmonella
"Shapiro, James",University of Alberta,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Preclinical Development of Novel Biomaterials for the Creation of a Deviceless Pre-Vascularized Site for Islet and Cellular Transplantation,"$157,126",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; ENDOCRINOLOGY; IMMUNOLOGY-TRANSPLANTATION; METABOLISM/DIABETES,2016-04-01,2017-03-31,preclinical development of novel biomaterials for the creation of a deviceless prevascularized site for islet and cellular transplantation
"Bernatchez, Pascal N",University of British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Novel compounds for treatment of pulmonary hypertension,"$158,389",$0,1 yr 0 mth ,Circulatory and Respiratory Health,HYPERTENSION; CARDIOVASCULAR; RESPIRATION,2013-04-01,2014-03-31,novel compounds for treatment of pulmonary hypertension
"Cunningham, Charles H","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Wire for MRI-Guided Interventions,"$139,840","$8,395",1 yr 0 mth ,Circulatory and Respiratory Health,CORONARY CIRCULATION (INCL. INSUFFICIENCY); IMAGING; CARDIOVASCULAR,2010-10-01,2011-09-30,wire for mriguided interventions
"Vanner, Stephen J","Queen's University (Kingston, Ontario)",Project Grant,202303PJT,Commercialization,Developing a potent non-addictive analgesic as an alternative to conventional opioids,"$665,550",$0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Commercialization-Industry Research & Development; Neurosciences-Sensory Systems (including visual, auditory and pain)",2023-10-01,2026-09-30,developing a potent nonaddictive analgesic as an alternative to conventional opioids
"Putnins, Edward E",University of British Columbia,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Development of Novel Polar MAO B Inhibitors for the Treatment of Epithelial Barrier Diseases,"$160,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,DENTAL DISEASE (INCL. ORAL BIOLOGY); DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DENTAL SCIENCE - Oral Biology; DRUG RESEARCH,2014-10-01,2015-09-30,development of novel polar mao b inhibitors for the treatment of epithelial barrier diseases
"Sarunic, Marinko V","Simon Fraser University (Burnaby, B.C.)",Project Grant,201809PJT,Commercialization,Sensorless Adaptive Optics Optical Coherence Tomography for Clinical Ophthalmology,"$493,425",$0,3 yrs 0 mth ,Aging,Biomedical Engineering-Biomedical Imaging,2017-04-01,2018-03-31,sensorless adaptive optics optical coherence tomography for clinical ophthalmology
"Pratt, Christine M",University of Ottawa,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,A-CD estrogens as alternatives to Estrogen-based hormone replacement therapy,"$156,060",$0,1 yr 0 mth ,Gender and Health,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; ENDOCRINOLOGY; DRUG RESEARCH; HEALTH RESEARCH,2012-10-01,2013-09-30,acd estrogens as alternatives to estrogenbased hormone replacement therapy
"Wither, Joan E",University Health Network (Toronto),Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Development of a test for the early diagnosis and monitoring of lupus nephritis,"$160,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"LUPUS; GENITO/URINARY SYSTEM; MUSCLE, BONE, OR JOINT; RENAL FUNCTION, NEPHROLOGY, UROLOGY",2016-04-01,2017-03-31,development of a test for the early diagnosis and monitoring of lupus nephritis
"Yanow, Stephanie K",University of Alberta,Proof of Principle Program - Phase II,201309PP2,Proof of Principle,A field-deployable malaria and fever diagnostic system,"$143,250",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; POPULATION HEALTH; INTERNATIONAL HEALTH,2014-04-01,2015-03-31,a fielddeployable malaria and fever diagnostic system
"Mahuran, Don J",Hospital for Sick Children (Toronto),Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Treating Parkinson's Disease with Drugs that Increase Lysosomal B-Glucocerebrosidase Activity,"$157,606",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",PARKINSON'S DISEASE; MENTAL AND BEHAVIOURAL DISEASES; NERVOUS SYSTEM; BIOCHEMISTRY,2012-04-01,2013-03-31,treating parkinsons disease with drugs that increase lysosomal bglucocerebrosidase activity
"Graham, Simon J","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Tablet Technology for Assessing Dementia,"$116,402",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",ALZHEIMER'S DISEASE; IMAGING; NERVOUS SYSTEM,2011-10-01,2012-09-30,tablet technology for assessing dementia
"Zaugg, Michael",University of Alberta,Project Grant,202303PJT,Commercialization,"Vegaven, a novel lipid emulsion with unique superior biological actions designed for parenteral nutrition","$818,550",$0,3 yrs 0 mth ,"Nutrition, Metabolism and Diabetes",Commercialization-Intellectual Property,2023-10-01,2026-09-30,vegaven a novel lipid emulsion with unique superior biological actions designed for parenteral nutrition
"Kizhakkedathu, Jayachandran N",University of British Columbia,Proof of Principle Program - Phase II,201402PP2,Proof of Principle,Preclinical Development of a Glucose-Free Peritoneal Dialysis Solution,"$289,799","$5,000",1 yr 0 mth ,"Nutrition, Metabolism and Diabetes","RENAL FUNCTION, NEPHROLOGY, UROLOGY",2014-10-01,2015-09-30,preclinical development of a glucosefree peritoneal dialysis solution
"Bosse, Yohan",Universite Laval,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Prognostic gene signature for stage I lung adenocarcinoma,"$148,348",$0,1 yr 0 mth ,Cancer Research,LUNG CANCER; SUPPLEMENTARY CLASSIFICATIONS; CANCER; GENETICS,2013-10-01,2014-09-30,prognostic gene signature for stage i lung adenocarcinoma
"Sutherland, Garnette R",University of Calgary,Project Grant,202303PJT,Commercialization,An Intelligent Workstation for Robot-Assisted Microsurgery & Tele-Operations,"$780,300",$0,3 yrs 0 mth ,Health Services and Policy Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation",2023-10-01,2026-09-30,an intelligent workstation for robotassisted microsurgery teleoperations
"Allard, Michael F",University of British Columbia,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Modulation of heart metabolism by hydrophobically modified hyperbranched polyglycerols,"$150,000",$0,1 yr 0 mth ,Circulatory and Respiratory Health,MYOCARDIAL INFARCTION; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CARDIOVASCULAR; DRUG RESEARCH,2009-07-01,2010-06-30,modulation of heart metabolism by hydrophobically modified hyperbranched polyglycerols
"Nanthakumar, Kumaraswamy",University Health Network (Toronto),Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Novel Mapping Methodology for Identifying Arrhythmia Circuit.,"$158,375",$0,1 yr 0 mth ,Circulatory and Respiratory Health,CARDIOLOGY; ARRHYTHMIAS; CARDIOVASCULAR,2014-04-01,2015-03-31,novel mapping methodology for identifying arrhythmia circuit
"Qadura, Mohammad",Unity Health Toronto,Project Grant,202109PJT,Commercialization,Artery Alert - Revolutionizing the Diagnosis of Peripheral Arterial Disease,"$428,400",$0,4 yrs 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Clinical and Translational Cardiovascular Sciences",2022-04-01,2026-03-31,artery alert revolutionizing the diagnosis of peripheral arterial disease
"Dutta, Tilak",University Health Network (Toronto),Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Pressure ulcer prevention: a novel prompting system for patient repositioning,"$137,401",$0,1 yr 0 mth ,Aging,SKIN AND SUBCUTANEOUS TISSUS; MULTIPLE DISEASE RELEVANCE; AGING; GERIATRICS,2016-04-01,2017-03-31,pressure ulcer prevention a novel prompting system for patient repositioning
"Poirier, Donald",Universite Laval,Project Grant,201709PJT,Commercialization,Demonstration de l'efficacite du premier inhibiteur irreversible et selectif de la  17beta-HSD1 pour le traitement des cancers du sein sensibles aux estrogenes,"$279,226",$0,2 yrs 0 mth ,Cancer Research,Cancer-Cancer Drug Development and Therapeutics,2018-04-01,2020-03-31,demonstration de lefficacite du premier inhibiteur irreversible et selectif de la 17betahsd1 pour le traitement des cancers du sein sensibles aux estrogenes
"Schang, Luis M",University of Alberta,Proof of Principle Program Phase I - Drug Development,200904PDD,Proof of Principle,Novel Inhibitors of Viral Infectivity,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; LIVER DISEASE; VIROLOGY; GASTROINTESTINAL (LIVER),2009-07-01,2010-06-30,novel inhibitors of viral infectivity
"Kizhakkedathu, Jayachandran N",University of British Columbia,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Novel Polymer Based Glucose-sparing Peritoneal Dialysis Solutions for End-stage Renal Disease,"$160,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes","RENAL FUNCTION, NEPHROLOGY, UROLOGY",2012-10-01,2013-09-30,novel polymer based glucosesparing peritoneal dialysis solutions for endstage renal disease
"Sutherland, Garnette R",University of Calgary,Project Grant,201709PJT,Commercialization,The SmartForceps System: An intelligent and innovative tool technology for recording surgical performance and skill,"$520,200",$0,3 yrs 0 mth ,Health Services and Policy Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Health Services and Systems-Healthcare Safety & Quality Improvement",2018-04-01,2021-03-31,the smartforceps system an intelligent and innovative tool technology for recording surgical performance and skill
"Lubell, William D",Universite de Montreal,Project Grant,202209PJT,Commercialization,"Treating Age-Related Macular Degeneration by Mitigating Inflammation, Oxidative Stress, and Lipid Accumulation through CD36 Modulation","$833,851",$0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Commercialization-Industry Research & Development; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery; Aging-Geriatric Medicine and Health Sciences",2023-04-01,2026-03-31,treating agerelated macular degeneration by mitigating inflammation oxidative stress and lipid accumulation through cd36 modulation
"Chan, Tak Hang",McGill University,Proof of Principle Program - Phase II,201109PP2,Proof of Principle,Evaluation of novel flavonoids in models of hematological cancer,"$300,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; NEOPLASMS; DRUG RESEARCH; CANCER,2012-04-01,2013-03-31,evaluation of novel flavonoids in models of hematological cancer
"Cummins, Carolyn L",University of Toronto,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Developing a Novel Therapeutic for Cushing's Syndrome,"$160,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",ENDOCRINOLOGY; MUSCULO SKELETAL; DRUG RESEARCH,2014-04-01,2015-03-31,developing a novel therapeutic for cushings syndrome
"Boerkoel, Cornelius F",University of British Columbia,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Development of Tdp1 inhibitors for treating cancer,"$159,927",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; NEOPLASMS; DRUG RESEARCH; CANCER,2011-10-01,2012-09-30,development of tdp1 inhibitors for treating cancer
"Jaffray, David A",University Health Network (Toronto),Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Advanced Handheld SPECT System for Intraoperative Guidance,"$159,845",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,2014-10-01,2015-09-30,advanced handheld spect system for intraoperative guidance
"Agrawal, Babita",University of Alberta,Project Grant,201903PJT,Commercialization,Development of a novel universal (cross-protective) vaccine technology for influenza viruses,"$367,200",$0,3 yrs 0 mth ,Infection and Immunity,"Commercialization-Intellectual Property; Immunology and Infection-Antiviral Drug Resistance, Viral Vaccine Development and Therapeutics (including vaccines)",2019-10-01,2022-09-30,development of a novel universal crossprotective vaccine technology for influenza viruses
"Greer, John J",University of Alberta,Proof of Principle Program - Phase II,201502PP2,Proof of Principle,Ampakine Therapy for Alleviating Respiratory Depression,"$145,440",$0,1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; NONE OF THE ABOVE; NERVOUS SYSTEM,2015-10-01,2016-09-30,ampakine therapy for alleviating respiratory depression
"Mes-Masson, Anne-Marie",Centre hospitalier de l'Universite de Montreal (CHUM),Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Development and validation of a multiplex blood-based assay for the early detection of ovarian cancer.,"$160,000",$0,1 yr 0 mth ,Cancer Research,GENITO/URINARY SYSTEM; NEOPLASMS; CANCER; HEALTH RESEARCH,2010-10-01,2011-09-30,development and validation of a multiplex bloodbased assay for the early detection of ovarian cancer
"Dacosta, Ralph S",University Health Network (Toronto),Proof of Principle Program - Phase I,201102PPP,Proof of Principle,"Development of PRODIGI, a Handheld Optical Imaging Technology for Real-time Intraoperative-guidance of Breast Tumour Resection","$121,250","$24,000",1 yr 0 mth ,Cancer Research,BREAST CANCER; BREAST CANCER THERAPY; IMAGING; CANCER,2011-10-01,2012-09-30,development of prodigi a handheld optical imaging technology for realtime intraoperativeguidance of breast tumour resection
"Kazem-Moussavi, Zahra M",University of Manitoba,Project Grant,201803PJT,Commercialization,Acoustical Device for Obstructive Sleep Apnea Severity Prediction during Wakefulness,"$367,200",$0,3 yrs 0 mth ,Circulatory and Respiratory Health,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Health Determinants-Etiology of Disease and Conditions",2018-10-01,2021-09-30,acoustical device for obstructive sleep apnea severity prediction during wakefulness
"Williams, Jason",Nova Scotia Health Authority (Halifax),Proof of Principle Program - Phase II,201309PP2,Proof of Principle,The Production of Decellularized Human Skin to Treat Chronic Diabetic Ulcers,"$145,760",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,DIABETES MELLITUS; SKIN AND SUBCUTANEOUS TISSUS; HEALTH RESEARCH; METABOLISM/DIABETES,2014-04-01,2015-03-31,the production of decellularized human skin to treat chronic diabetic ulcers
"Lam, Stephen",University of British Columbia,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,CTAP III for detection of early lung cancer and monitoring treatment outcome,"$160,000",$0,1 yr 0 mth ,Cancer Research,LUNG CANCER; CANCER,2010-10-01,2011-09-30,ctap iii for detection of early lung cancer and monitoring treatment outcome
"Weaver, Donald F",IWK Health Centre (Halifax),Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Pharmacokinetic Optimization of a New Drug for Alzheimer's Disease,"$150,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",ALZHEIMER'S DISEASE; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; NERVOUS SYSTEM,2010-04-01,2011-03-31,pharmacokinetic optimization of a new drug for alzheimers disease
"Brodt, Pnina",Research Institute of the McGill University Health Centre,Proof of Principle Program - Phase II,201502PP2,Proof of Principle,An IGF-Trap for the treatment of breast cancer: consolidation of the pre-clinical profile and commercialization.,"$299,934",$0,1 yr 0 mth ,Cancer Research,BREAST CANCER; BREAST CANCER THERAPY; CANCER; DRUG RESEARCH,2015-10-01,2016-09-30,an igftrap for the treatment of breast cancer consolidation of the preclinical profile and commercialization
"Houde, Daniel",Universite de Sherbrooke,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Radiotherapie par filamentation laser femtoseconde,"$112,602",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; BRAIN TUMORS THERAPY; CANCER; BIOPHYSICS,2011-04-01,2012-03-31,radiotherapie par filamentation laser femtoseconde
"Kremer, Richard B",Research Institute of the McGill University Health Centre,Project Grant,202209PJT,Commercialization,Anti-parathyroid hormone-related protein (PTHrP) monoclonal antibodies against metastatic cancer,"$665,550",$0,3 yrs 0 mth ,Cancer Research,"Commercialization-Technology Transfer; Musculoskeletal Health-Bone, Skin and Cartilage Sciences; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",2023-04-01,2026-03-31,antiparathyroid hormonerelated protein pthrp monoclonal antibodies against metastatic cancer
"Hassell, John A",McMaster University,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Characterization of small molecule sensitizers to chemotherapy,"$160,000",$0,1 yr 0 mth ,Cancer Research,BREAST CANCER THERAPY; BREAST CANCER; CANCER; DRUG RESEARCH,2012-04-01,2013-03-31,characterization of small molecule sensitizers to chemotherapy
"Yousef, George M",Unity Health Toronto,Project Grant,201809PJT,Commercialization,Development of the first pre-operative serum exosomal miRNA test to guide treatment decision in prostate cancer,"$573,752",$0,4 yrs 0 mth ,Cancer Research,Cancer-Cancer Progression and Metastasis,2019-04-01,2023-03-31,development of the first preoperative serum exosomal mirna test to guide treatment decision in prostate cancer
"Wang, Yuzhuo",University of British Columbia,Project Grant,202109PJT,Commercialization,Optimization and Validation of MCT4-targeting Small Molecule Inhibitors for Treatment of Advanced Cancers,"$1,147,500",$0,5 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property; Cancer-Cancer Drug Development and Therapeutics,2022-04-01,2027-03-31,optimization and validation of mct4targeting small molecule inhibitors for treatment of advanced cancers
"Reiner, Neil E",University of British Columbia,Proof of Principle Program - Phase II,200810PP2,Proof of Principle,INDEL therapeutics for the treatment of infectious disease.,"$250,000",$0,1 yr 0 mth ,Infection and Immunity,"INFECTIOUS AND PARASITIC; GENOMICS, PROTEOMICS, AND BIOINFORMATICS; DRUG RESEARCH",2009-01-01,2009-12-31,indel therapeutics for the treatment of infectious disease
"Biddiss, Elaine A",Holland Bloorview Kids Rehabilitation Hospital (Toronto),Project Grant,201909PJT,Commercialization,"BootleBlast, a movement tracking video game for home-based motor therapy - Navigating gaps to market readiness","$409,276",$0,3 yrs 0 mth ,"Human Development, Child and Youth Health",Commercialization-Technology Transfer,2020-04-01,2023-03-31,bootleblast a movement tracking video game for homebased motor therapy navigating gaps to market readiness
"Nepveu, Alain",McGill University,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Validation of the CUX1 Expression Signature as an RT-PCR-Based Prognostic Tool,"$159,950",$0,1 yr 0 mth ,Cancer Research,BREAST CANCER; NEOPLASMS; CANCER; MOLECULAR BIOLOGY,2011-04-01,2012-03-31,validation of the cux1 expression signature as an rtpcrbased prognostic tool
"Meek, Robert N",University of British Columbia,Proof of Principle Program - Phase II,201302PP2,Proof of Principle,Minimally Invasive Curved Intramedullary Fixation (MICIF) for pelvic bone fractures,"$300,000",$0,1 yr 0 mth ,Health Services and Policy Research,"NONE OF THE ABOVE; MUSCLE, BONE, OR JOINT; HEALTH RESEARCH",2013-10-01,2014-09-30,minimally invasive curved intramedullary fixation micif for pelvic bone fractures
"Moreau, Alain","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Methods of Diagnosing Primary Osteoarthritis,"$160,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"ARTHRITIS/OSTEOARTHRITIS; MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; CELL BIOLOGY",2011-04-01,2012-03-31,methods of diagnosing primary osteoarthritis
"Riddell, Michael C","York University (Toronto, Ontario)",Proof of Principle Program Phase I - Drug Development,201102PDD,Proof of Principle,Pharmaceutical intervention to decrease the threat of hypoglycemia in insulin-treated diabetics,"$160,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; ENDOCRINOLOGY; METABOLISM/DIABETES,2011-10-01,2012-09-30,pharmaceutical intervention to decrease the threat of hypoglycemia in insulintreated diabetics
"Slim, Rima",McGill University,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,NLRP7-based diagnosis of female reproduction wastage,"$160,000",$0,1 yr 0 mth ,Genetics,PREGNANCY/BIRTH; PERINATAL; GENETICS; REPRODUCTION/PREGNANCY,2012-10-01,2013-09-30,nlrp7based diagnosis of female reproduction wastage
"Kastrup, Christian J",University of British Columbia,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Self-Propelling Hemostatic Particles that Treat Severe Bleeding,"$159,788",$0,1 yr 0 mth ,Circulatory and Respiratory Health,CLOTTING DEFECTS/THROMBOSIS; PREGNANCY/BIRTH; CARDIOVASCULAR; BLOOD,2014-10-01,2015-09-30,selfpropelling hemostatic particles that treat severe bleeding
"Burt, Helen M",University of British Columbia,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Intravesical Taxanes,"$157,412",$0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; DRUG RESEARCH,2012-04-01,2013-03-31,intravesical taxanes
"Stagljar, Igor",University of Toronto,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,"Development of the Mammalian Membrane Two-Hybrid (MaMTH) technology, a novel protein interaction and drug discovery tool","$160,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; MULTIPLE DISEASE RELEVANCE; MOLECULAR BIOLOGY; BIOCHEMISTRY,2013-04-01,2014-03-31,development of the mammalian membrane twohybrid mamth technology a novel protein interaction and drug discovery tool
"Kizhakkedathu, Jayachandran N",University of British Columbia,Project Grant,202010PJT,Commercialization,Novel Infection Resistant Coating in an Era of Drug Resistant Bacteria for the Treatment and Prevention of Medical Device Infection,"$520,199",$0,3 yrs 0 mth ,Infection and Immunity,"Commercialization-Intellectual Property; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",2021-04-01,2024-03-31,novel infection resistant coating in an era of drug resistant bacteria for the treatment and prevention of medical device infection
"Brinkman, Ryan",University of British Columbia,Project Grant,201909PJT,Commercialization,Machine Learning for Flow Cytometry Clinical Data and Trial Analysis,"$317,475",$0,1 yr 10 mths ,Infection and Immunity,Commercialization-Technology Transfer; Methods Development and Modelling-Quantitative Methods Development for Health Research,2020-04-01,2022-01-31,machine learning for flow cytometry clinical data and trial analysis
"Roberge, Michel",University of British Columbia,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Preclinical evaluation of a gentamicin analog as a treatment for genetic diseases and cancer due to a premature termination codon.,"$150,059",$0,1 yr 0 mth ,Genetics,MULTIPLE DISEASE RELEVANCE; CANCER THERAPY GENERAL; CANCER; GENETICS,2016-04-01,2017-03-31,preclinical evaluation of a gentamicin analog as a treatment for genetic diseases and cancer due to a premature termination codon
"Mueller, Christopher R","Queen's University (Kingston, Ontario)",Project Grant,202209PJT,Commercialization,Using a Liquid Biopsy to Optimize Metastatic Breast Cancer Treatment,"$891,226",$0,3 yrs 0 mth ,Cancer Research,Cancer-Cancer Progression and Metastasis; Cancer-Clinical Oncology; Commercialization-Industry Research & Development,2023-04-01,2026-03-31,using a liquid biopsy to optimize metastatic breast cancer treatment
"Fernie, Geoffrey R",University Health Network (Toronto),Proof of Principle Program - Phase II,201202PP2,Proof of Principle,A novel point-of-care method of handling human waste in healthcare institutions: technical improvements and evaluation.,"$51,544",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; NONE OF THE ABOVE; NOT CLASSIFIED,2012-10-01,2013-09-30,a novel pointofcare method of handling human waste in healthcare institutions technical improvements and evaluation
"Liu, Fang",Centre for Addiction and Mental Health (Toronto),Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Therapeutics targeting receptor-receptor interactions for Addiction,"$150,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DRUG RESEARCH; MENTAL HEALTH,2010-04-01,2011-03-31,therapeutics targeting receptorreceptor interactions for addiction
"Garnis, Cathie",University of British Columbia,Project Grant,202309PJT,Commercialization,Blood based biomarker for the early detection of recurrent oropharyngeal cancer,"$474,300",$0,4 yrs 0 mth ,Cancer Research,Cancer-Cancer Progression and Metastasis; Cancer-Clinical Oncology,2024-04-01,2028-03-31,blood based biomarker for the early detection of recurrent oropharyngeal cancer
"Chen, Yen-I",Research Institute of the McGill University Health Centre,Project Grant,202309PJT,Commercialization,A novel through-the-scope exchangeable double balloon catheter to guide endoscopic bypass:  a practice-changing technology in the management of malignant gastric outlet obstruction,"$451,350",$0,2 yrs 0 mth ,"Nutrition, Metabolism and Diabetes",,2024-03-01,2025-02-28,a novel throughthescope exchangeable double balloon catheter to guide endoscopic bypass a practicechanging technology in the management of malignant gastric outlet obstruction
"Wu, Jian Hui",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Proof of Principle Program Phase I - Drug Development,201003PDD,Proof of Principle,Novel bifunctional antiandrogens that suppress oncogenic activation of the androgen receptor in castration-resistant prostate cancer,"$159,750",$0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; CANCER; ENDOCRINOLOGY,2010-10-01,2011-09-30,novel bifunctional antiandrogens that suppress oncogenic activation of the androgen receptor in castrationresistant prostate cancer
"Tremblay, Michel L",McGill University,Proof of Principle Program Phase I - Drug Development,201003PDD,Proof of Principle,Discovery and uses of a new class of small molecule inhibitors of tyrosine phosphatases.,"$158,850",$0,1 yr 0 mth ,Cancer Research,MULTIPLE DISEASE RELEVANCE; BREAST CANCER THERAPY; BIOCHEMISTRY; DRUG RESEARCH,2010-10-01,2011-09-30,discovery and uses of a new class of small molecule inhibitors of tyrosine phosphatases
"Nazhat, Showan N",McGill University,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Injectable dense collagen-silk fibroin derived polypeptide hydrogels for bone regenerative therapy,"$156,393",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"MUSCULO SKELETAL; DENTAL DISEASE (INCL. ORAL BIOLOGY); MUSCLE, BONE, OR JOINT; AGING",2013-04-01,2014-03-31,injectable dense collagensilk fibroin derived polypeptide hydrogels for bone regenerative therapy
"Beg, Mirza Faisal","Simon Fraser University (Burnaby, B.C.)",Project Grant,202303PJT,Commercialization,Staging the host in Cancer: AI-based automated comprehensive body composition assessment for Precision Medicine,"$956,250",$0,3 yrs 0 mth ,Cancer Research,Biomedical Engineering-Biomedical Imaging; Artificial Intelligence-Machine Learning; Commercialization-Industry Research & Development,2023-10-01,2026-09-30,staging the host in cancer aibased automated comprehensive body composition assessment for precision medicine
"Chemtob, Sylvain","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Proof of Principle Program - Phase II,201003PP2,Proof of Principle,IL-1  Allosteramers to treat diabetes and its complications,"$300,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; METABOLISM/DIABETES; VISION,2010-10-01,2011-09-30,il1 allosteramers to treat diabetes and its complications
"Bell, John C",Ottawa Hospital Research Institute,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Increasing vaccine manufacturing output using viral sensitizer technology,"$136,750",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; VIRAL; HEALTH RESEARCH; VIROLOGY,2011-04-01,2012-03-31,increasing vaccine manufacturing output using viral sensitizer technology
"Leonardi, Mathew",McMaster University,Project Grant,202309PJT,Commercialization,Commercialization of a diagnostic test for endometriosis,"$634,949",$0,3 yrs 0 mth ,Gender and Health,"Sex-and-Gender Health-Sex-and-Gender-Based Analysis - Clinical, Health Systems and Population Health Research",2024-04-01,2027-03-31,commercialization of a diagnostic test for endometriosis
"Akbari, Mohsen",University of Victoria (British Columbia),Project Grant,202303PJT,Commercialization,Towards commercialization of GelDerm-a smart dressing for continuous wound monitoring,"$332,776",$0,2 yrs 0 mth ,Musculoskeletal Health and Arthritis,Commercialization-Industry Research & Development,2023-10-01,2025-09-30,towards commercialization of gelderma smart dressing for continuous wound monitoring
"Guertin, Pierre",Universite Laval,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,A Novel Class of Drug Treatment Against Chronic Constipation in Spinal Cord-Injured People,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",SPINAL CORD DISEASE; GASTRO-INTESTINAL DISEASE; NERVOUS SYSTEM; GASTROINTESTINAL (LIVER),2013-10-01,2014-09-30,a novel class of drug treatment against chronic constipation in spinal cordinjured people
"Minchinton, Andrew I",University of British Columbia,Project Grant,201903PJT,Commercialization,Hypoxia-activated DNA repair inhibitors to improve cancer therapy,"$573,750",$0,3 yrs 0 mth ,Cancer Research,Cancer-Cancer Drug Development and Therapeutics,2019-10-01,2022-09-30,hypoxiaactivated dna repair inhibitors to improve cancer therapy
"Poirier, Donald",Universite Laval,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,L'evaluation du potentiel therapeutique in vivo d'une nouvelle famille d'aminosteroides comme agents anticancereux selectifs,"$149,703",$0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER THERAPY GENERAL; DRUG RESEARCH; CANCER,2010-04-01,2011-03-31,levaluation du potentiel therapeutique in vivo dune nouvelle famille daminosteroides comme agents anticancereux selectifs
"Park, Morag",McGill University,Proof of Principle Program - Phase II,200904PP2,Proof of Principle,Generation of a gene expression-based breast cancer prognostic device,"$73,500",$0,1 yr 0 mth ,Cancer Research,"BREAST CANCER; BREAST CANCER THERAPY; CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",2009-07-01,2010-06-30,generation of a gene expressionbased breast cancer prognostic device
"Boivin, Guy",Universite Laval,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,New antiviral agents against herpes simplex viruses,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; VIROLOGY; DRUG RESEARCH,2010-04-01,2011-03-31,new antiviral agents against herpes simplex viruses
"Frost, Eric H",Universite de Sherbrooke,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,"Simultaneous Influenza A detection, subtyping, and oseltamivir resistance determination","$95,000","$65,000",1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; MULTIPLE DISEASE RELEVANCE; VIROLOGY; HEALTH RESEARCH,2011-10-01,2012-09-30,simultaneous influenza a detection subtyping and oseltamivir resistance determination
"Hanrahan, John W",McGill University,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,CFTR modulators as a potential new therapeutic paradigm to treat individuals with COPD,"$159,665",$0,1 yr 0 mth ,Circulatory and Respiratory Health,CHRONIC OBSTRUCTIVE LUNG DISEASE; RESPIRATION; HEALTH RESEARCH,2014-10-01,2015-09-30,cftr modulators as a potential new therapeutic paradigm to treat individuals with copd
"Booth, Valerie K",Memorial University of Newfoundland,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,HLA Peptide Development as a Therapeutic for Psoriasis,"$156,920",$0,1 yr 0 mth ,Infection and Immunity,SKIN AND SUBCUTANEOUS TISSUS; BIOCHEMISTRY; DRUG RESEARCH,2011-04-01,2012-03-31,hla peptide development as a therapeutic for psoriasis
"Hunter, Graeme K",Western University (Ontario),Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Crystal-binding peptides for prevention of kidney stone disease,"$116,350","$6,000",1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",GENITO/URINARY SYSTEM; ATHEROSCLEROSIS; DRUG RESEARCH; BIOPHYSICS,2009-07-01,2010-06-30,crystalbinding peptides for prevention of kidney stone disease
"Tavallaei, Mohammad A",Toronto Metropolitan University,Project Grant,202403PJT,Commercialization,Design Revisions and Validations of a Catheter Steering and Navigation System For Peripheral Endovascular Revascularization,"$501,076",$0,3 yrs 0 mth ,Circulatory and Respiratory Health,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation",2024-10-01,2027-09-30,design revisions and validations of a catheter steering and navigation system for peripheral endovascular revascularization
"Cripton, Peter A",University of British Columbia,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Pro-Neck-Tor: A helmet to prevent spinal cord injuries occuring during sports and transportation,"$149,752",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"INJURY, REGENERATION; MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; NERVOUS SYSTEM",2009-07-01,2010-06-30,pronecktor a helmet to prevent spinal cord injuries occuring during sports and transportation
"Santamaria, Pere",University of Calgary,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Evaluation of Nanoparticles for the Treatment of Autoimmune Conditions,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,ENDOCRINOLOGY; DIABETES MELLITUS; IMMUNOLOGY-TRANSPLANTATION; METABOLISM/DIABETES,2009-01-01,2009-12-31,evaluation of nanoparticles for the treatment of autoimmune conditions
"Drangova, Maria",Western University (Ontario),Project Grant,202010PJT,Commercialization,Contact-force controller to eliminate the effects of motion during cardiac radiofrequency ablation,"$367,200",$0,2 yrs 0 mth ,Circulatory and Respiratory Health,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation",2021-04-01,2023-03-31,contactforce controller to eliminate the effects of motion during cardiac radiofrequency ablation
"Fenster, Aaron",Western University (Ontario),Proof of Principle Program - Phase I,201309PPP,Proof of Principle,3D Ultrasound Scanner System For Management Of Intraventricular Hemorrhage In Preterm Neonates,"$148,062",$0,1 yr 0 mth ,"Human Development, Child and Youth Health",MULTIDISCIPLINARY; NONE OF THE ABOVE; IMAGING; BIOPHYSICS,2014-04-01,2015-03-31,3d ultrasound scanner system for management of intraventricular hemorrhage in preterm neonates
"Banerjee, Diponkar",University of British Columbia,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Validation of Tissue and Cytology Microarray Spotter (TCMS) for Simultaneous Multiple Biomarker Detection in Cells,"$150,000",$0,1 yr 0 mth ,Cancer Research,NEOPLASMS; NONE OF THE ABOVE; CANCER; MOLECULAR BIOLOGY,2009-01-01,2009-12-31,validation of tissue and cytology microarray spotter tcms for simultaneous multiple biomarker detection in cells
"Gatignol, Anne",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Development of antisense-based small RNA agents targeting the GAG open reading frame of HIV-1 RNA for use in gene and drug therapy against HIV-1 infection.,"$159,550",$0,1 yr 0 mth ,Infection and Immunity,AIDS; VIRAL; VIROLOGY; MOLECULAR BIOLOGY,2014-04-01,2015-03-31,development of antisensebased small rna agents targeting the gag open reading frame of hiv1 rna for use in gene and drug therapy against hiv1 infection
"Pinto, Mario","Simon Fraser University (Burnaby, B.C.)",Proof of Principle Program - Phase I,200810PPP,Proof of Principle,An Enzyme Inhibitor for Treating Type-2 Diabetes,"$150,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; METABOLISM AND NUTRITION; METABOLISM/DIABETES; BIOCHEMISTRY,2009-01-01,2009-12-31,an enzyme inhibitor for treating type2 diabetes
"Sibille, Etienne",Centre for Addiction and Mental Health (Toronto),Project Grant,201803PJT,Commercialization,Novel therapeutic targeting for cognitive deficits in depression and aging,"$550,800",$0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction",Mental Health and Behavioural Conditions-Mental Health and Addiction; Aging-Aging Process and Biological Determinants of Aging,2018-10-01,2021-09-30,novel therapeutic targeting for cognitive deficits in depression and aging
"Schweizer, Frank",University of Manitoba,Project Grant - Priority Announcement: Infection and Immunity + Project Grant,201909PJ4 + 202003PJT,Commercialization,Rescuing beta-lactam antibiotic/beta-lactamase inhibitor combinations from resistance against multidrug-resistant Gram-negative pathogens,"$754,075",$0,5 yr 0 mth  ,Infection and Immunity,"Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",2020-03-01,2021-02-28,rescuing betalactam antibioticbetalactamase inhibitor combinations from resistance against multidrugresistant gramnegative pathogens
"Doschak, Michael R",University of Alberta,Proof of Principle Program Phase I - Drug Development,201003PDD,Proof of Principle,Bisphosphonate-conjugated Calcitonin,"$117,929",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; MUSCULO SKELETAL; DRUG RESEARCH; MUSCLE, BONE, OR JOINT",2010-10-01,2011-09-30,bisphosphonateconjugated calcitonin
"Diallo, Jean-Simon",Ottawa Hospital Research Institute,Proof of Principle Program - Phase II,201402PP2,Proof of Principle,Evaluation of viral sensitizer technology in improving egg-based influenza vaccine manufacturing processes,"$222,143","$77,857",1 yr 0 mth ,Infection and Immunity,VIRAL; NONE OF THE ABOVE; VIROLOGY; BIOCHEMISTRY,2014-10-01,2015-09-30,evaluation of viral sensitizer technology in improving eggbased influenza vaccine manufacturing processes
"C.-Gaudreault, Rene",Universite Laval,Project Grant,201709PJT,Commercialization,Validation of Highly Potent Substituted Phenyl Alkylureas as Antipsoriatic Agents,"$497,250",$0,3 yrs 0 mth ,Cancer Research,"Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Action, Toxicology and Metabolism; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",2018-04-01,2021-03-31,validation of highly potent substituted phenyl alkylureas as antipsoriatic agents
"Burns, David H",McGill University,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Smart Ultrasonic Hydrogel Sensors for Point of Care Analysis,"$150,000",$0,1 yr 0 mth ,Circulatory and Respiratory Health,,2009-01-01,2009-12-31,smart ultrasonic hydrogel sensors for point of care analysis
"Fraser, Paul E",University of Toronto,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Amyloid-Based Therapies for Type 2 Diabetes,"$150,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; METABOLISM AND NUTRITION; METABOLISM/DIABETES; BIOCHEMISTRY,2009-01-01,2009-12-31,amyloidbased therapies for type 2 diabetes
"Weaver, Donald F",University Health Network (Toronto),Project Grant,201709PJT,Commercialization,"Design and Development of Brain Permeant Indoleamine-2,3-Dioxygenase Inhibitors","$765,000",$0,4 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery; Neurosciences-Neurological disorders",2018-04-01,2022-03-31,design and development of brain permeant indoleamine23dioxygenase inhibitors
"Lerouge, Sophie",ecole de technologie superieure (Montreal),Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Injectable thermosensitive hydrogel as delivery vehicle of lymphocytes for cancer immunotherapy,"$141,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,2016-04-01,2017-03-31,injectable thermosensitive hydrogel as delivery vehicle of lymphocytes for cancer immunotherapy
"Kumar, Rakesh",University of Alberta,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Development of novel chemotherapeutics for tuberculosis,"$159,850",$0,1 yr 0 mth ,Infection and Immunity,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; INFECTIOUS AND PARASITIC; DRUG RESEARCH; BACTERIOLOGY,2014-04-01,2015-03-31,development of novel chemotherapeutics for tuberculosis
"Hysi, Eno",Unity Health Toronto,Project Grant,202403PJT,Commercialization,Commercialization of H-scan: a new tool for imaging kidney fibrosis,"$726,750",$0,3 yrs 0 mth ,"Nutrition, Metabolism and Diabetes","Commercialization-Intellectual Property; Biomedical Engineering-Biomedical Imaging; Digestive, Endocrine and Excretory Systems-Nephrology and Urology",2024-10-01,2027-09-30,commercialization of hscan a new tool for imaging kidney fibrosis
"Tremblay, Jacques P",Universite Laval,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Development of a treatment for Friedreich ataxia based on the administration of TALE proteins targeting the frataxin promoter.,"$160,000",$0,1 yr 0 mth ,Genetics,CONGENITAL ANOMALIES; MOLECULAR BIOLOGY,2013-04-01,2014-03-31,development of a treatment for friedreich ataxia based on the administration of tale proteins targeting the frataxin promoter
"Kushki, Azadeh",Holland Bloorview Kids Rehabilitation Hospital (Toronto),Project Grant,202003PJT,Commercialization,A wearable technology approach to managing challenging behaviours in children with autism spectrum disorder (ASD),"$485,774",$0,3 yrs 0 mth ,"Human Development, Child and Youth Health",Commercialization-Technology Transfer,2020-10-01,2023-09-30,a wearable technology approach to managing challenging behaviours in children with autism spectrum disorder asd
"Huntsman, David G",University of British Columbia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,A Diagnostic Test for Granulosa Cell Tumours of the Ovary,"$150,000",$0,1 yr 0 mth ,Cancer Research,CANCER,2010-04-01,2011-03-31,a diagnostic test for granulosa cell tumours of the ovary
"Boyd, Daniel",Dalhousie University (Nova Scotia),Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Commercialization of a Radiopaque Spherical Embolic Agent.,"$159,097",$0,1 yr 0 mth ,"Human Development, Child and Youth Health",NOT CLASSIFIED,2012-10-01,2013-09-30,commercialization of a radiopaque spherical embolic agent
"Schimmer, Aaron D",University Health Network (Toronto),Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Repositioning tigecycline for the treatment of leukemia,"$156,750",$0,1 yr 0 mth ,Cancer Research,LEUKAEMIAS; CANCER THERAPY GENERAL; CANCER; CELL BIOLOGY,2011-04-01,2012-03-31,repositioning tigecycline for the treatment of leukemia
"Petkovich, Martin","Queen's University (Kingston, Ontario)",Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Blocking RA Metabolism: A safer approach to retinoid therapy in skin disease,"$135,557",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",SKIN AND SUBCUTANEOUS TISSUS; METABOLISM AND NUTRITION; DRUG RESEARCH; BIOCHEMISTRY,2012-04-01,2013-03-31,blocking ra metabolism a safer approach to retinoid therapy in skin disease
"Martin, Ruth E",Western University (Ontario),Proof of Principle Program - Phase II,200904PP2,Proof of Principle,"Swallowing Air-Pulse Therapy (SWAPT): Design Specification, Testing, Regulatory Approval, and Pre-launch Market Analysis","$250,000",$0,1 yr 0 mth ,Aging,"STROKE, HEART FAILURE; MUSCULO SKELETAL; AGING; DENTAL SCIENCE - Oral Biology",2009-07-01,2010-06-30,swallowing airpulse therapy swapt design specification testing regulatory approval and prelaunch market analysis
"Wu, Xiao Yu S",University of Toronto,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Preclinical evaluation of multifunctional polymer nanoparticles for targeted brain cancer therapy,"$160,000",$0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; CANCER,2014-04-01,2015-03-31,preclinical evaluation of multifunctional polymer nanoparticles for targeted brain cancer therapy
"Roberge, Michel",University of British Columbia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Evaluation of the anticancer activity of a new autophagy-inhibitory drug,"$142,989",$0,1 yr 0 mth ,Cancer Research,BREAST CANCER THERAPY; LUNG CANCER THERAPY; CANCER; BIOCHEMISTRY,2010-04-01,2011-03-31,evaluation of the anticancer activity of a new autophagyinhibitory drug
"Kelley, Shana O",University of Toronto,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Clinical validation of low-cost ultrasensitive electronic molecular  diagnostics,"$150,000",$0,1 yr 0 mth ,Genetics,MULTIPLE DISEASE RELEVANCE; GENETICS,2009-01-01,2009-12-31,clinical validation of lowcost ultrasensitive electronic molecular diagnostics
"Kotra, Lakshmi P",University Health Network (Toronto),Proof of Principle Program - Phase I,201402PPP,Proof of Principle,In vivo efficacy studies on KP-218 as a potential MS therapeutic agent,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE SCLEROSIS; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS,2014-10-01,2015-09-30,in vivo efficacy studies on kp218 as a potential ms therapeutic agent
"Steinberg, Gregory R",McMaster University,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Development of a new therapy targeting adipose tissue metabolism for the treatment of obesity,"$160,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",OBESITY; ENDOCRINOLOGY; METABOLISM/DIABETES,2014-10-01,2015-09-30,development of a new therapy targeting adipose tissue metabolism for the treatment of obesity
"Verma, Subodh S",Unity Health Toronto,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Evaluation of BRCA1 as a Novel Therapeutic Strategy for Endothelial Dysfunction and Atherosclerosis,"$149,998",$0,1 yr 0 mth ,Circulatory and Respiratory Health,ATHEROSCLEROSIS; CARDIOVASCULAR,2009-07-01,2010-06-30,evaluation of brca1 as a novel therapeutic strategy for endothelial dysfunction and atherosclerosis
"Schweizer, Frank",University of Manitoba,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Preclinical evaluation of antimicrobial ultrashort aminoglycoside- peptide conjugates,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; HEALTH RESEARCH,2009-01-01,2009-12-31,preclinical evaluation of antimicrobial ultrashort aminoglycoside peptide conjugates
"Li, Shyh-Dar","Ontario Institute for Cancer Research (Toronto, Ontario)",Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Heat-triggered Chemotherapy to Treat Refractory Breast Cancer at the Chest Wall,"$160,000",$0,1 yr 0 mth ,Cancer Research,DRUG RESEARCH; CANCER,2013-10-01,2014-09-30,heattriggered chemotherapy to treat refractory breast cancer at the chest wall
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Proof of Principle Program - Phase II,200910PP2,Proof of Principle,Neuroprotection Rescue Strategies for Retinal Degeneration Diseases,"$250,000",$0,1 yr 0 mth ,Aging,DISEASES AFFECTING SPEECH/VISION/HEARING; AGING; VISION,2010-04-01,2011-03-31,neuroprotection rescue strategies for retinal degeneration diseases
"Beg, Mirza Faisal","Simon Fraser University (Burnaby, B.C.)",Project Grant - Priority Announcement: Cancer Research,202209PJS,Commercialization,Novel end-to-end platform for extraction of body composition measurements from CT images for research and integration into clinical workflows for precision medicine,"$100,000",$0,1 yr 0 mth ,Cancer Research,Biomedical Engineering-Biomedical Imaging; Artificial Intelligence-Machine Learning; Commercialization-Industry Research & Development,2023-03-01,2024-02-29,novel endtoend platform for extraction of body composition measurements from ct images for research and integration into clinical workflows for precision medicine
"Mcalpine, Jessica N",University of British Columbia,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,PROMISE: A Proactive Molecular-Based Classification Tool to Improve Endometrial Cancer Management,"$160,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,2016-04-01,2017-03-31,promise a proactive molecularbased classification tool to improve endometrial cancer management
"Reynolds, Steven C","Fraser Health Authority (Surrey, BC)",Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Phase 1 Trial of a novel transvenous phrenic nerve pacer for diaphragm activation in mechanically ventilated critically ill patients.,"$158,464","$1,536",1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; HEALTH RESEARCH,2013-04-01,2014-03-31,phase 1 trial of a novel transvenous phrenic nerve pacer for diaphragm activation in mechanically ventilated critically ill patients
"Shoichet, Molly S",University of Toronto,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Commercial Development of Bioengineered Therapeutic Strategy for Spinal Cord Injury,"$159,996",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",SPINAL CORD DISEASE; NERVOUS SYSTEM,2010-10-01,2011-09-30,commercial development of bioengineered therapeutic strategy for spinal cord injury
"Hancock, Robert Ernest W",University of British Columbia,Proof of Principle Program Phase I - Drug Development,201102PDD,Proof of Principle,Novel anti-inflammatory treatment for Amyotrophic Lateral Sclerosis,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; AMYOTROPHIC LATERAL SCLEROSIS (ALS); DRUG RESEARCH; NERVOUS SYSTEM,2011-10-01,2012-09-30,novel antiinflammatory treatment for amyotrophic lateral sclerosis
"Prentki, Marc",Centre hospitalier de l'Universite de Montreal (CHUM),Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Validation of a glycerolipid/ free fatty acid cycling enzyme as a novel therapeutic target for type-2 diabetes,"$157,925",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; METABOLISM AND NUTRITION; METABOLISM/DIABETES; DRUG RESEARCH,2011-10-01,2012-09-30,validation of a glycerolipid free fatty acid cycling enzyme as a novel therapeutic target for type2 diabetes
"Sadar, Marianne D",University of British Columbia,Proof of Principle Program - Phase II,201102PP2,Proof of Principle,Translational Development Program For Analogues of EPI-001 (PNG01-185) Compounds For the Treatment of Advanced Prostate Cancer,"$300,000",$0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; CANCER; DRUG RESEARCH,2011-10-01,2012-09-30,translational development program for analogues of epi001 png01185 compounds for the treatment of advanced prostate cancer
"Minchinton, Andrew I",University of British Columbia,Project Grant,202309PJT,Commercialization,Development of clinical candidate hypoxia-activated DNA-PK inhibitors,"$979,200",$0,4 yrs 0 mth ,Cancer Research,Cancer-Cancer Drug Development and Therapeutics,2024-04-01,2028-03-31,development of clinical candidate hypoxiaactivated dnapk inhibitors
"Jarvi, Keith A",Sinai Health System (Toronto),Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Prediction of successful sperm retrieval in patients with non-obstructive azoospermia using a panel of protein biomarkers measured in seminal plasma,"$154,660",$0,1 yr 0 mth ,"Human Development, Child and Youth Health","INFERTILITY MALE; PREGNANCY/BIRTH; GENOMICS, PROTEOMICS, AND BIOINFORMATICS; REPRODUCTION/PREGNANCY",2013-10-01,2014-09-30,prediction of successful sperm retrieval in patients with nonobstructive azoospermia using a panel of protein biomarkers measured in seminal plasma
"Chopra, Rajiv","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Proof of Principle Program - Phase II,201102PP2,Proof of Principle,Evaluation of MRI-controlled interstitial ultrasound therapy for the treatment of cerebral neoplasms,"$147,500",$0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; IMAGING; CANCER,2011-10-01,2012-09-30,evaluation of mricontrolled interstitial ultrasound therapy for the treatment of cerebral neoplasms
"Richter, Martin",Universite de Sherbrooke,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Matriptase Inhibitors as a Novel Class of Influenza Antivirals,"$143,827",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; VIROLOGY; DRUG RESEARCH,2012-04-01,2013-03-31,matriptase inhibitors as a novel class of influenza antivirals
"Jarzem, Peter F",McGill University,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,"Minimally Invasive Ready, Highly Expandable Vertebral Body Replacement Device","$122,826",$0,1 yr 0 mth ,Cancer Research,"BONE CANCER; MUSCULO SKELETAL; NERVOUS SYSTEM; MUSCLE, BONE, OR JOINT",2010-04-01,2011-03-31,minimally invasive ready highly expandable vertebral body replacement device
"Beaulieu, Jean-Franeois",Universite de Sherbrooke,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Improving the diagnosis of colorectal cancer using fecal mRNA and protein markers: The integrin alpha 6A subunit,"$160,000",$0,1 yr 0 mth ,Cancer Research,GASTRO-INTESTINAL CANCER; GASTRO-INTESTINAL CANCER THERAPY; GASTROINTESTINAL (LIVER); CANCER,2014-04-01,2015-03-31,improving the diagnosis of colorectal cancer using fecal mrna and protein markers the integrin alpha 6a subunit
"Tabrizian, Maryam",McGill University,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,A Novel Injectable Chitosan Sponge Containing BMP-7 as a Therapeutic Intervention for Accelerated Bone Formation in a Critical Size Defect Rat Model,"$160,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"BONE CANCER; INJURY, REGENERATION; MUSCLE, BONE, OR JOINT; DRUG RESEARCH",2014-10-01,2015-09-30,a novel injectable chitosan sponge containing bmp7 as a therapeutic intervention for accelerated bone formation in a critical size defect rat model
"Weinfeld, Michael",University of Alberta,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Small molecule inhibitor of polynucleotide kinase/phosphatase and uses thereof in cancer treatment.,"$150,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,2010-04-01,2011-03-31,small molecule inhibitor of polynucleotide kinasephosphatase and uses thereof in cancer treatment
"Doschak, Michael R",University of Alberta,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Bone-Seeking Iron Oxide Nanoparticles for Imaging Bone Metabolism,"$160,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; MUSCULO SKELETAL; DRUG RESEARCH; MUSCLE, BONE, OR JOINT",2016-04-01,2017-03-31,boneseeking iron oxide nanoparticles for imaging bone metabolism
"Afilalo, Jonathan",McGill University,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Buccal Lamin A as a Novel Biomarker for Frailty,"$160,000",$0,1 yr 0 mth ,Aging,AGING; CARDIOLOGY; CELL BIOLOGY,2013-04-01,2014-03-31,buccal lamin a as a novel biomarker for frailty
"Bell, John C",Ottawa Hospital Research Institute,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Biological Viral Sensitizers for GMP Manufacturing,"$123,000","$37,000",1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; VIRAL; CANCER; VIROLOGY,2014-04-01,2015-03-31,biological viral sensitizers for gmp manufacturing
"Unrau, Peter J","Simon Fraser University (Burnaby, B.C.)",Project Grant,202210PJT,Commercialization,Commercialization of RNA Mango fluorogenic aptamers: RNA Pulldown and Imaging Tools for Therapeutic and Diagnostic pipelines,"$100,000",$0,1 yr 0 mth ,Infection and Immunity,"Commercialization-Intellectual Property; Commercialization-Technology Transfer; Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",2023-04-01,2024-03-31,commercialization of rna mango fluorogenic aptamers rna pulldown and imaging tools for therapeutic and diagnostic pipelines
"Fenster, Aaron",Western University (Ontario),Proof of Principle Program - Phase I,201509PPP,Proof of Principle,MR-Guided Focal Ablation of Prostate Cancer,"$143,110","$10,313",1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; IMAGING; CANCER,2016-04-01,2017-03-31,mrguided focal ablation of prostate cancer
"Ross, Ruth A",University of Toronto,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Development and therapeutic validation of GPR55 modulators for the treatment of osteoclast-mediated disorders,"$155,600",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"OSTEOPOROSIS; BONE CANCER; MUSCLE, BONE, OR JOINT; CANCER",2016-04-01,2017-03-31,development and therapeutic validation of gpr55 modulators for the treatment of osteoclastmediated disorders
"Rennie, Paul S",University of British Columbia,"Proof of Principle - PA: Cancer Early Detection, Imaging/Trans Therapeutics",200904PCA,Proof of Principle,Androgen receptor inhibitors,"$150,000",$0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; ENDOCRINOLOGY; CANCER; DRUG RESEARCH,2009-07-01,2010-06-30,androgen receptor inhibitors
"Zhou, Youwen",University of British Columbia,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,A diagnostic test for cutaneous T cell lymphomas,"$151,660",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; BLOOD; CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",2012-10-01,2013-09-30,a diagnostic test for cutaneous t cell lymphomas
"Pearson, Christopher E",Hospital for Sick Children (Toronto),Project Grant,202309PJT,Commercialization,Pre-clinical studies of a small-molecule to reverse neurodegenerative disease-causing mutations for its commercialization and application,"$719,101",$0,3 yrs 0 mth ,Genetics,Commercialization-Technology Transfer; Genetics-Molecular and Functional Genetics and Epigenetics,2024-04-01,2027-03-31,preclinical studies of a smallmolecule to reverse neurodegenerative diseasecausing mutations for its commercialization and application
"Ghahary, Aziz",University of British Columbia,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Discovery of a Novel Anti-fibrogenic factor and its Therapeutic evaluation,"$150,932",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; INJURY, REGENERATION",2012-04-01,2013-03-31,discovery of a novel antifibrogenic factor and its therapeutic evaluation
"Kelley, Shana O",University of Toronto,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Preclinical testing of a mitochondrially-targeted anticancer agent,"$160,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER; GENETICS,2012-04-01,2013-03-31,preclinical testing of a mitochondriallytargeted anticancer agent
"Agrawal, Babita",University of Alberta,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,New dual-mode antiviral agents for the treatment of hepatitis C virus infection,"$159,984",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUG RESEARCH; VIROLOGY,2013-10-01,2014-09-30,new dualmode antiviral agents for the treatment of hepatitis c virus infection
"Yang, Victor X",Toronto Metropolitan University,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Integrated Surgical Lighting and Navigation System,"$156,230","$2,200",1 yr 0 mth ,Musculoskeletal Health and Arthritis,"MUSCULO SKELETAL; MULTIDISCIPLINARY; IMAGING; MUSCLE, BONE, OR JOINT",2013-10-01,2014-09-30,integrated surgical lighting and navigation system
"Grynpas, Marc D",Sinai Health System (Toronto),Proof of Principle Program - Phase I,201009PPP,Proof of Principle,"""Calcium Polyphosphate Bone Substitutes""","$156,022",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"OSTEOPOROSIS; AGING; MUSCLE, BONE, OR JOINT",2011-04-01,2012-03-31,calcium polyphosphate bone substitutes
"Alain, Tommy",Children's Hospital of Eastern Ontario Research Institute Inc,Project Grant - PA: Breast Cancer Research,202403PLL,Commercialization,Viralyzing transgenes to improve oncolytic immunotherapy.,"$100,000",$0,1 yr 0 mth ,Cancer Research,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Genetics-Genomics, Transcriptomics and Proteomics; Immunology and Infection-Virology",2023-03-01,2024-02-29,viralyzing transgenes to improve oncolytic immunotherapy
"Bohbot, Veronique",CIUSSS de l'Ouest-de-l'Ile-de-Montreal-Douglas Hospital,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Validation of a fully automated virtual reality based spatial memory improvement program that promotes healthy aging,"$160,000",$0,1 yr 0 mth ,Aging,ALZHEIMER'S DISEASE; HEALTH PROMOTION,2014-10-01,2015-09-30,validation of a fully automated virtual reality based spatial memory improvement program that promotes healthy aging
"Chopra, Rajiv","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Development of endorectal MR elastography for prostate cancer detection,"$153,344",$0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; IMAGING; CANCER,2011-04-01,2012-03-31,development of endorectal mr elastography for prostate cancer detection
"Charron, Thierry",CIUSSS du Nord-de-l'Ile-de Montreal - Hepital Sacre Coeur,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Innovative device to reduce myocardial infarct size and no-reflow : Proof of concepts in humans,"$159,300",$0,1 yr 0 mth ,Circulatory and Respiratory Health,MYOCARDIAL INFARCTION; CARDIOLOGY; CARDIOVASCULAR,2014-04-01,2015-03-31,innovative device to reduce myocardial infarct size and noreflow proof of concepts in humans
"Gleave, Martin E",University of British Columbia,Project Grant,201709PJT,Commercialization,Preclinical development of a novel androgen receptor antagonist to treat castration-resistant prostate cancer,"$351,900",$0,2 yrs 0 mth ,Cancer Research,Cancer-Cancer Drug Development and Therapeutics,2018-04-01,2020-03-31,preclinical development of a novel androgen receptor antagonist to treat castrationresistant prostate cancer
"Snutch, Terrance P",University of British Columbia,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Identification of SLC26A11 blockers to prevent neuronal swelling and cell death,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",CNS ORGANIC; MULTIPLE DISEASE RELEVANCE; DRUG RESEARCH; NERVOUS SYSTEM,2016-04-01,2017-03-31,identification of slc26a11 blockers to prevent neuronal swelling and cell death
"Liu, Fang",Centre for Addiction and Mental Health (Toronto),Proof of Principle Program - Phase II,201509PP2,Proof of Principle,Development and commercialisation of a novel treatment for multiple sclerosis,"$299,101",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE SCLEROSIS; MENTAL AND BEHAVIOURAL DISEASES; DRUG RESEARCH; NERVOUS SYSTEM,2016-04-01,2017-03-31,development and commercialisation of a novel treatment for multiple sclerosis
"Sadar, Marianne D",University of British Columbia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Preclinical evaluation of sintokamides as agents for treatment of advanced prostate cancer,"$150,000",$0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; PROSTATE AND BLADDER CANCER THERAPY; CANCER; ENDOCRINOLOGY,2010-04-01,2011-03-31,preclinical evaluation of sintokamides as agents for treatment of advanced prostate cancer
"Brown, Jeremy A",Dalhousie University (Nova Scotia),Proof of Principle Program - Phase I,201003PPP,Proof of Principle,A High-Resolution Ultrasonic Endoscope for the Auditory System,"$108,000","$10,600",1 yr 0 mth ,Aging,DEAFNESS; DISEASES AFFECTING SPEECH/VISION/HEARING; IMAGING; HEARING,2010-10-01,2011-09-30,a highresolution ultrasonic endoscope for the auditory system
"Kizhakkedathu, Jayachandran N",University of British Columbia,Project Grant,202209PJT,Commercialization,Localized immuno-cloaking organ engineering approach to prevent transplant rejection without immunosuppressants,"$803,250",$0,3 yrs 0 mth ,Infection and Immunity,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Immunology and Infection-Transplantation, Immune Tolerance and Tumor Immunology; Commercialization-Intellectual Property",2023-04-01,2026-03-31,localized immunocloaking organ engineering approach to prevent transplant rejection without immunosuppressants
"Uludag, Hasan",University of Alberta,Project Grant,202210PJT,Commercialization,New Treatment of Blood Cancers with Improved Delivery of Nucleic Acids,"$100,000",$0,1 yr 0 mth ,Cancer Research,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Cancer-Cancer Drug Development and Therapeutics; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",2023-04-01,2024-03-31,new treatment of blood cancers with improved delivery of nucleic acids
"Cynader, Max S",University of British Columbia,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Novel peptide as potential therapeutic for treatment of ischemic stroke,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction","STROKE, HEART FAILURE",2012-04-01,2013-03-31,novel peptide as potential therapeutic for treatment of ischemic stroke
"Fon, Edward A",McGill University,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Targeting Alpha-Synuclein Propagation in the Treatment of Parkinson's Disease and Other Synucleinopathies,"$159,946",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",PARKINSON'S DISEASE; AGING; NERVOUS SYSTEM; DRUG RESEARCH,2014-10-01,2015-09-30,targeting alphasynuclein propagation in the treatment of parkinsons disease and other synucleinopathies
"Pelletier, Jerry M",McGill University,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Chemotherapeutic Agents for Inhibiting Protein Synthesis,"$160,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; NEOPLASMS; DRUG RESEARCH; CANCER,2011-10-01,2012-09-30,chemotherapeutic agents for inhibiting protein synthesis
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Project Grant - PA: Cancer Research - Cancer Prevention + Project Grant,202010PXX + 202104PJT,Commercialization,Innovation of Proprietary Liquid Biopsy Assays for Diagnosis of Early Stage Ovarian Cancer,"$750,251",$0,3 yr 0 mth  ,Cancer Research,"Commercialization-Technology Transfer; Cancer-Cancer Progression and Metastasis; Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; glycomics. We quantify gangliosides which are glycolipids with a glycan and a lipid component",2021-10-01,2023-09-30,innovation of proprietary liquid biopsy assays for diagnosis of early stage ovarian cancer
"Shlien, Adam",Hospital for Sick Children (Toronto),Project Grant,202303PJT,Commercialization,Development of an RNA-based test for diagnosing and monitoring bone and soft tissue cancers,"$240,976",$0,1 yr 0 mth ,Cancer Research,Cancer-Cancer Progression and Metastasis; Commercialization-Technology Transfer; Artificial Intelligence-Machine Learning,2023-10-01,2024-09-30,development of an rnabased test for diagnosing and monitoring bone and soft tissue cancers
"Sonenberg, Nahum",McGill University,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Identification of novel compounds inhibiting viral infections,"$150,000",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; MULTIPLE DISEASE RELEVANCE; VIROLOGY; MOLECULAR BIOLOGY,2009-01-01,2009-12-31,identification of novel compounds inhibiting viral infections
"Lerouge, Sophie",ecole de technologie superieure (Montreal),Proof of Principle Program - Phase I,201003PPP,Proof of Principle,A new therapeutic agent for the treatment and prevention of endoleaks after endovascular aneurysm repair,"$155,000",$0,1 yr 0 mth ,Circulatory and Respiratory Health,ATHEROSCLEROSIS; CARDIOVASCULAR,2010-10-01,2011-09-30,a new therapeutic agent for the treatment and prevention of endoleaks after endovascular aneurysm repair
"Coderre, Terence J",McGill University,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Synergistic topical combinations for chronic pain aimed at treating microvascular dysfunction.,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE DISEASE RELEVANCE; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; NERVOUS SYSTEM,2012-10-01,2013-09-30,synergistic topical combinations for chronic pain aimed at treating microvascular dysfunction
"Rosenberg, Lawrence",McGill University,Proof of Principle Program - Phase II,201209PP2,Proof of Principle,A Novel Regenerative Drug Therapy to Restore Natural Insulin Secretion in Diabetes Mellitus,"$122,670",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; METABOLISM/DIABETES,2013-04-01,2014-03-31,a novel regenerative drug therapy to restore natural insulin secretion in diabetes mellitus
"Beaulieu, Martin",Universite Laval,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Cells lines for screening GPCR/Nav signaling compound,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; CELL BIOLOGY,2013-10-01,2014-09-30,cells lines for screening gpcrnav signaling compound
"Meloche, Sylvain",Universite de Montreal,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Targeting the degradation of the cyclin-dependent kinase inhibitor p21 as a novel approach to cancer therapy,"$160,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; NEOPLASMS; DRUG RESEARCH; CANCER,2011-04-01,2012-03-31,targeting the degradation of the cyclindependent kinase inhibitor p21 as a novel approach to cancer therapy
"Agrawal, Babita",University of Alberta,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Novel cross-protective (universal) vaccine for influenza infections,"$159,990",$0,1 yr 0 mth ,Infection and Immunity,VIRAL; IMMUNOLOGY-TRANSPLANTATION,2012-10-01,2013-09-30,novel crossprotective universal vaccine for influenza infections
"Haddad, Elie","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Project Grant,202209PJT,Commercialization,Empowering innovative hematopoietic stem cells (HSC)-based cancer immunotherapy through the creation of synthetic specific promoters,"$765,000",$0,4 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property; Commercialization-Technology Transfer; Cancer-Cancer Drug Development and Therapeutics,2023-04-01,2027-03-31,empowering innovative hematopoietic stem cells hscbased cancer immunotherapy through the creation of synthetic specific promoters
"Hansen, Carl L",University of British Columbia,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Pre-commercial development of single cell antibody selection process,"$154,120",$0,1 yr 0 mth ,Infection and Immunity,MULTIPLE DISEASE RELEVANCE; MULTIDISCIPLINARY; IMMUNOLOGY-TRANSPLANTATION; HEALTH RESEARCH,2012-10-01,2013-09-30,precommercial development of single cell antibody selection process
"Hebert, Marc",Universite Laval,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,"Diagnostic differentiel de la schizophrenie, la depression bipolaire et la depression majeure e l'aide de l'electroretinographie","$159,700",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DEPRESSION; MENTAL HEALTH,2014-04-01,2015-03-31,diagnostic differentiel de la schizophrenie la depression bipolaire et la depression majeure e laide de lelectroretinographie
"Zeng, Haishan",University of British Columbia,Project Grant,202409PJT,Commercialization,Endoscopic Laser Raman Spectroscopy for Minimally Invasive Detection of Peripheral Lung Cancer,"$814,724",$0,4 yrs 0 mth ,Cancer Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Cancer-Clinical Oncology; Musculoskeletal Health-Oral Health",2021-10-01,2025-09-30,endoscopic laser raman spectroscopy for minimally invasive detection of peripheral lung cancer
"Wu, Jian Hui",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Development of novel pan-inhibitors of the androgen receptor variants as effective therapeutics for castration-resistant prostate cancer,"$160,000",$0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; CANCER; ENDOCRINOLOGY,2010-10-01,2011-09-30,development of novel paninhibitors of the androgen receptor variants as effective therapeutics for castrationresistant prostate cancer
"Magolan, Jakob",McMaster University,Project Grant,202409PJT,Commercialization,Advanced pre-clinical development of selective IMPDH2 inhibitors for the treatment and prevention of brain metastases.,"$1,162,800",$0,2 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Action, Toxicology and Metabolism; Neurosciences-Neurological disorders",2022-04-01,2025-03-31,advanced preclinical development of selective impdh2 inhibitors for the treatment and prevention of brain metastases
"Moreau, Alain","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Preclinical Validation of a Disease-Modifying Osteoarthritis Drug,"$160,000",$0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"ARTHRITIS/OSTEOARTHRITIS; SKIN AND SUBCUTANEOUS TISSUS; MUSCLE, BONE, OR JOINT; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",2014-05-01,2014-07-31,preclinical validation of a diseasemodifying osteoarthritis drug
"Foster, Leonard J",University of British Columbia,Project Grant - PA: Pandemic Preparedness and Health Emergencies Research + Project Grant - PA: Pandemic Preparedness and Health Emergencies Research,"202309PPE, 202403PPE",Commercialization,Development and Commercialization of a Safe and Effective Mpox Subunit Vaccine witheGlobaleImpact,"$200,000",$0,2 yr 0 mth ,Population and Public Health,"Population and Health-Health Promotion and Disease Prevention; Immunology and Infection-Antiviral Drug Resistance, Viral Vaccine Development and Therapeutics (including vaccines)",2024-03-01,2025-02-28,development and commercialization of a safe and effective mpox subunit vaccine witheglobaleimpact
"Tsao, Ming-Sound",University Health Network (Toronto),Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Development of a monoclonal antibody for integrin alpha-11 to treat lung cancer,"$160,000",$0,1 yr 0 mth ,Cancer Research,GASTRO-INTESTINAL CANCER; GASTRO-INTESTINAL DISEASE; IMAGING; CANCER,2017-04-01,2020-03-31,development of a monoclonal antibody for integrin alpha11 to treat lung cancer
"Crome, Sarah A",University Health Network (Toronto),Project Grant,202409PJT,Commercialization,Development of a novel immunoregulatory cell therapy,"$990,675",$0,5 yrs 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER; BIOPHYSICS,2017-05-01,2019-04-30,development of a novel immunoregulatory cell therapy
"Ross, Ruth A",University of Toronto,Proof of Principle Program - Phase II,201409PP2,Proof of Principle,Development and Commercialisation of Allosteric Modulators for the Treatment of Pain,"$189,920",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE DISEASE RELEVANCE; ARTHRITIS/OSTEOARTHRITIS; DRUG RESEARCH; AGING,2013-04-01,2014-03-31,development and commercialisation of allosteric modulators for the treatment of pain
"Kim, Peter K",Hospital for Sick Children (Toronto),Proof of Principle Program - Phase I,201502PPP,Proof of Principle,A novel therapeutic treatment for Zellweger Spectrum Disorder,"$160,000",$0,1 yr 0 mth ,"Human Development, Child and Youth Health","Molecular, Cellular and Systems Biology-Cell Biology and Physiology; Molecular, Cellular and Systems Biology-Cell Signaling; Molecular, Cellular and Systems Biology-Molecular Biology",2024-04-01,2029-03-31,a novel therapeutic treatment for zellweger spectrum disorder
"Dyck, Jason R",University of Alberta,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Preclinical Development and Optimization of Small Molecules for the Treatment of Atrial Fibrillation,"$160,000",$0,1 yr 0 mth ,Cancer Research,"Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Action, Toxicology and Metabolism; Cancer-Cancer Drug Development and Therapeutics",2023-04-01,2027-03-31,preclinical development and optimization of small molecules for the treatment of atrial fibrillation
"Tsantrizos, Youla S",McGill University,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Benchmark proprietary pyridine- and thienopyrimidine-based bisphosphonates against the standard of care drug Zometae in the treatment of multiple myeloma,"$160,000",$0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; BONE CANCER THERAPY; DRUG RESEARCH; CANCER,2014-04-01,2015-03-31,benchmark proprietary pyridine and thienopyrimidinebased bisphosphonates against the standard of care drug zometae in the treatment of multiple myeloma
"Olson, David M",University of Alberta,Project Grant,202409PJT,Commercialization,Prolonging gestation and improving newborn outcomes with a novel IL-1 receptor modulator,"$1,269,901",$0,3 yrs 0 mth ,Cancer Research,ENDOCRINOLOGY; NONE OF THE ABOVE; MOLECULAR BIOLOGY,2005-04-01,2009-03-31,prolonging gestation and improving newborn outcomes with a novel il1 receptor modulator
"Chauhan, Vijay S",University Health Network (Toronto),Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Rotor Mapping in Human Atrial Fibrillation,"$149,015","$10,634",1 yr 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Cardiovascular and Circulatory Sciences; Molecular, Cellular and Systems Biology-Cell Biology and Physiology",2017-04-01,2018-03-31,rotor mapping in human atrial fibrillation
"Ma, Hongshen",University of British Columbia,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Pre-commercial Development of Microfluidic Technology for Deformability based Separation of Circulating Tumor Cells,"$160,000",$0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; PROSTATE AND BLADDER CANCER THERAPY; CANCER; GENETICS,2017-04-01,2020-03-31,precommercial development of microfluidic technology for deformability based separation of circulating tumor cells
"Sinton, David A",University of Toronto,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,High Quality Sperm Selection for Assisted Reproductive Technology,"$159,904",$0,1 yr 0 mth ,"Human Development, Child and Youth Health",INFERTILITY FEMALE; NONE OF THE ABOVE; REPRODUCTION/PREGNANCY; CELL BIOLOGY,2005-04-01,2010-03-31,high quality sperm selection for assisted reproductive technology
"Macaulay, Calum E",University of British Columbia,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Optically-Guided Biopsy for Improved Diagnosis of Peripheral Pulmonary Nodules,"$146,470",$0,1 yr 0 mth ,,,2021-05-01,2022-04-30,opticallyguided biopsy for improved diagnosis of peripheral pulmonary nodules
"Reynolds, Steven C","Fraser Health Authority (Surrey, BC)",Proof of Principle Program - Phase II,201409PP2,Proof of Principle,"Development of a novel, temporary, transcutaneously placed, transvenous phrenic nerve pacer for diaphragm activation in critically ill patients","$268,499","$2,000",1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; HEALTH RESEARCH,2013-04-01,2014-03-31,development of a novel temporary transcutaneously placed transvenous phrenic nerve pacer for diaphragm activation in critically ill patients
"Sheppard, Donald C",Research Institute of the McGill University Health Centre,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Recombinant hydrolases as anti-biofilm therapies for Aspergillus infections,"$151,459",$0,1 yr 0 mth ,Population and Public Health,INFECTIOUS AND PARASITIC; HEALTH RESEARCH,2012-05-01,2015-04-30,recombinant hydrolases as antibiofilm therapies for aspergillus infections
"Trifiro, Mark A",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Targeting novel BioNanofluids for prostate cancer therapy,"$148,240","$11,000",1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; IMAGING; CANCER,2014-10-01,2015-09-30,targeting novel bionanofluids for prostate cancer therapy
"Boisselier Mailfait, Elodie",Universite Laval,Project Grant,202003PJT,Commercialization,Un nouveau vecteur de medicaments ophtalmiques e base de nanoparticules d'or,"$550,800",$0,5 yrs 0 mth ,"Neurosciences, Mental Health and Addiction",Commercialization-Intellectual Property,2020-10-01,2025-09-30,un nouveau vecteur de medicaments ophtalmiques e base de nanoparticules dor
"Poirier, Donald",Universite Laval,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,evaluation du potentiel therapeutique in vivo d'un nouvel inhibiteur de la steroede sulfatase combinant des proprietes osteogenique et antiestrogenique pour le traitement des cancers du sein et de la prostate,"$159,756",$0,1 yr 0 mth ,Cancer Research,BREAST CANCER THERAPY; OSTEOPOROSIS; CANCER; DRUG RESEARCH,2014-04-01,2015-03-31,evaluation du potentiel therapeutique in vivo dun nouvel inhibiteur de la steroede sulfatase combinant des proprietes osteogenique et antiestrogenique pour le traitement des cancers du sein et de la prostate
"Koeberle, Paulo D",University of Toronto,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Peptide therapeutics for preventing retinal ganglion cell apoptosis,"$149,949",$0,1 yr 0 mth ,Cancer Research,LEUKAEMIAS; CANCER THERAPY GENERAL; CANCER; BIOPHYSICS,2004-07-01,2006-06-30,peptide therapeutics for preventing retinal ganglion cell apoptosis
"Logsetty, Sarvesh",University of Manitoba,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,The effects of a novel hydrogel coating on commercial antimicrobial dressings.,"$157,633",$0,1 yr 0 mth ,,,2021-05-01,2022-04-30,the effects of a novel hydrogel coating on commercial antimicrobial dressings
"Du, Caigan",University of British Columbia,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Preclinical Development of a Novel Organ Transplant Solution,"$160,000",$0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes","RENAL FUNCTION, NEPHROLOGY, UROLOGY",2014-10-01,2015-09-30,preclinical development of a novel organ transplant solution
"Poirier, Donald",Universite Laval,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Optimisation du potentiel therapeutique de derives aminosteroedes contre le cancer de l'ovaire,"$157,700","$2,300",1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER THERAPY GENERAL; DRUG RESEARCH; CANCER,2016-04-01,2017-03-31,optimisation du potentiel therapeutique de derives aminosteroedes contre le cancer de lovaire
"Tremblay, Jacques P",Universite Laval,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Alzheimer treatment based on the editing of the Amyloid Precursor Protein gene,"$159,931",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",ALZHEIMER'S DISEASE; MENTAL AND BEHAVIOURAL DISEASES; NERVOUS SYSTEM; MENTAL HEALTH,2010-04-01,2015-03-31,alzheimer treatment based on the editing of the amyloid precursor protein gene
"Weksberg, Rosanna",Hospital for Sick Children (Toronto),Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Implementation and Commercialization of a Novel DNA Methylation-Based Diagnostic Tool,"$160,000",$0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE SCLEROSIS; MENTAL AND BEHAVIOURAL DISEASES; DRUG RESEARCH; NERVOUS SYSTEM,2016-04-01,2017-03-31,implementation and commercialization of a novel dna methylationbased diagnostic tool
"Poirier, Donald",Universite Laval,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,evaluation du potentiel therapeutique in vivo d'un nouvel inhibiteur de la 17beta-HSD3 e bloquer la croissance de tumeurs xenogreffees du cancer de la prostate,"$157,880",$0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; DRUG RESEARCH; CANCER,2012-10-01,2013-09-30,evaluation du potentiel therapeutique in vivo dun nouvel inhibiteur de la 17betahsd3 e bloquer la croissance de tumeurs xenogreffees du cancer de la prostate
"Russell, James A",University of British Columbia,Project Grant,202409PJT,Commercialization,Development of Lipid nanoparticle RNA systems as novel therapeutics for endotoxemia resulting from severe bacterial infections,"$719,101",$0,3 yrs 0 mth ,,,,,development of lipid nanoparticle rna systems as novel therapeutics for endotoxemia resulting from severe bacterial infections
"Foster, Leonard J",University of British Columbia,Project Grant - Priority Announcement: Global Health Research - CRPPHE,202409GL1,Commercialization,Accelerating Next-Generation Vaccine Development to Combat the Global Mpox Crisis,"$100,000",$0,1 yr 0 mth ,,,,,accelerating nextgeneration vaccine development to combat the global mpox crisis
"Flynn, Lauren E",Western University (Ontario),Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Development of novel porous extracellular matrix-derived bioscaffolds for cutaneous wound healing,"$160,000",$0,1 yr 0 mth ,,,,,development of novel porous extracellular matrixderived bioscaffolds for cutaneous wound healing
"Withers, Stephen G",University of British Columbia,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Extending circulation time of protein therapeutics by capping glycan structures with 7F-Sialic acids,"$159,981",$0,1 yr 0 mth ,,,,,extending circulation time of protein therapeutics by capping glycan structures with 7fsialic acids
"Lai, Yongjun","Queen's University (Kingston, Ontario)",Project Grant,202409PJT,Commercialization,Smart Contact Lens Sensors to Advance Intraocular Pressure Monitoring for Glaucoma Patients and At-Risk Individuals,"$596,700",$0,3 yrs 0 mth ,,,,,smart contact lens sensors to advance intraocular pressure monitoring for glaucoma patients and atrisk individuals
"Yanow, Stephanie K",University of Alberta,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Long-term preservation of a whole parasite malaria vaccine for storage and delivery in the tropics,"$160,000",$0,1 yr 0 mth ,,,,,longterm preservation of a whole parasite malaria vaccine for storage and delivery in the tropics
"Shrivastav, Anuraag",University of Winnipeg,Project Grant - Priority Announcement: Early Detection/Cancer Prevention,202409DCP,Commercialization,Efficacy of NMT2-Blood Test in Detecting Colorectal Polyps and Cancer,"$100,000",$0,1 yr 0 mth ,,,,,efficacy of nmt2blood test in detecting colorectal polyps and cancer
"Gibbings, Derrick J",University of Ottawa,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Technology to build a drug delivery platform for silencing RNAs using exosomes,"$159,941",$0,1 yr 0 mth ,,,,,technology to build a drug delivery platform for silencing rnas using exosomes
"Benard, Francois",University of British Columbia,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,"Advancing the clinical development of [18F]AMBF3-TATE, a novel imaging probe for neuroendocrine tumours","$160,000",$0,1 yr 0 mth ,,,,,advancing the clinical development of 18fambf3tate a novel imaging probe for neuroendocrine tumours
"Bergeron, Michel G",Universite Laval,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,"Developpement, optimisation et multiplexage d'un oligonucleotide synthetique permettant l'amplification d'ADN et l'hybridation sur support solide en une seule etape. PDP PhaseI","$160,000",$0,1 yr 0 mth ,,,,,developpement optimisation et multiplexage dun oligonucleotide synthetique permettant lamplification dadn et lhybridation sur support solide en une seule etape pdp phasei
"Hoare, Todd R",McMaster University,Project Grant,202409PJT,Commercialization,"Validation of injectable, long-lasting, and ultra-lubricious hydrogels for effective osteoarthritis treatment","$673,201",$0,3 yrs 0 mth ,,,,,validation of injectable longlasting and ultralubricious hydrogels for effective osteoarthritis treatment
"Brukner, Ivan",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,A new qPCR method for the assessment of total/relative bacterial load from stool samples: C difficile show case,"$131,513",$0,1 yr 0 mth ,,,,,a new qpcr method for the assessment of totalrelative bacterial load from stool samples c difficile show case
"Dumont, Guy A",University of British Columbia,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Certifiably safe closed-loop control of anesthesia,"$158,740",$0,1 yr 0 mth ,,,,,certifiably safe closedloop control of anesthesia
"MacVicar, Brian A",University of British Columbia,Project Grant,202409PJT,Commercialization,Lipid Nanoparticle-messenger RNA (LNP-mRNA) as a versatile therapeutic platform for brain diseases,"$577,574",$0,3 yrs 0 mth ,,,,,lipid nanoparticlemessenger rna lnpmrna as a versatile therapeutic platform for brain diseases
"Sidhu, Sachdev S",University of Toronto,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Highly specific therapeutic-grade anti-FGFR1 antibodies with anti-proliferative effects,"$160,000",$0,1 yr 0 mth ,,,,,highly specific therapeuticgrade antifgfr1 antibodies with antiproliferative effects
"de Rezende, Joao B",Unity Health Toronto,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,A Non-Traumatic Binder for Temporary Abdominal Wall Closure,"$115,768",$0,1 yr 0 mth ,,,,,a nontraumatic binder for temporary abdominal wall closure
"Young, Robert N","Simon Fraser University (Burnaby, B.C.)",Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Development of a novel conjugate drug for local delivery in bone grafts: Efficacy study on vascularization and osteogenesis after local delivery in a dental implant jaw model,"$157,500",$0,1 yr 0 mth ,,,,,development of a novel conjugate drug for local delivery in bone grafts efficacy study on vascularization and osteogenesis after local delivery in a dental implant jaw model
"Grierson, David S",University of British Columbia,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Development of Specific Inhibitors of HIV pre-mRNA Alternative Splicing: A New Anti-HIV/AIDS Strategy,"$160,000",$0,1 yr 0 mth ,,,,,development of specific inhibitors of hiv premrna alternative splicing a new antihivaids strategy
"Yoo, Paul",University of Toronto,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Minimally-Invasive Method of Selectively Activating Posterior Tibial Nerve Afferents for Treating Overactive Bladder,"$155,800","$4,000",1 yr 0 mth ,,,,,minimallyinvasive method of selectively activating posterior tibial nerve afferents for treating overactive bladder
